 Herbicidally and insecticidally effective 4-phenyl-substitued pyridazinones
专利摘要:
The invention relates to the phenyl-substituted pyridazinones of formula (I) for use as herbicides and insecticides. In formula (I), A, B, G, X, Y and Z represent groups such as hydrogen, organic groups such as alkyl, and other groups such as halogen, nitro and cyano. 公开号:AU2009328607A1 申请号:U2009328607 申请日:2009-12-12 公开日:2011-07-07 发明作者:Pierre Cristau；Jan Dittgen；Dieter Feucht；Reiner Fischer；Eva-Maria Franken；Oliver Gaertzen；Isolde Hauser-Hahn；Stefan Herrmann；Stefan Lehr；Olga Malsam；Christopher Hugh Rosinger；Thomas Schenke 申请人:Bayer CropScience AG； IPC主号:C07D237-16
专利说明:
WO 2010/069525 PCT/EP20091008908 Description Herbicidally and insecticidally effective 4-phenyl-substituted pyridazinones 5 The invention relates to the technical field of the crop protection agents, in particular that of the herbicides for the selective control of broad-leaved weed and weed grasses in crops of useful plants. O It specifically relates to 4-phenyl-substituted pyridazinones, processes for their preparation and their use as herbicides and insecticides. Various publications describe substituted 4-phenylpyridazinones having herbicidal properties. 2-Methyl-4-phenylpyridazinones are known from Stevenson et. al, J. Het. 5 Chem., (2005), 427 ff W02007/119434 Al describes 4-phenylpyridazinones which carry an alkyl radical in the 2-position of the phenyl ring. W02009/035150 A2 discloses 4-phenylpyridazinones which carry an alkyl or alkoxy radical in the 2 position of the phenyl ring and are optionally substituted at the other positions by halogen atoms or other radicals. 0 However, the compounds known from these publications frequently have insufficient herbicidal activity. Accordingly, it is an object of the present invention to provide alternative herbicidally active compounds. 5 It has been found that 4-phenylpyridazinones whose phenyl ring carries certain substituents are particularly suitable as herbicides. The present invention provides 4-phenylpyridazinones of the formula (1) or salts thereof 0 WO 2010/069525 PCT/EP20091008908 2 A OG N B 0 x in which A is in each case independently of one another hydrogen, (C 3 -C 6 )-cycloalkyl or (C1 5 C 6 )-alkyl substituted by n radicals from the group consisting of halogen, (C 3 -C 6 ) cycloalkyl, phenyl and halophenyl, B is independently of one another (C 3 -C 6 )-cycloalkyl or (C1-C6)-alkyl substituted by n radicals from the group consisting of halogen, (C 3 -C 6 )-cycloalkyl, phenyl and halophenyl; 0 m is 0,1, 2 or 3; n is 0, 1, 2 or 3, with the proviso that m and n are not both 0; 5 G is hydrogen, C(=O)R 1 , C(=L)MR 2 , S0 2 R 3 , P(=L)R 4 R 5 , C(=L)NRR, E or R8; E is a metal ion equivalent or an ammonium ion; L is oxygen or sulfur; !0 M is oxygen or sulfur; R 1 is (C1-C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 1 -C4)-alkoxy-(C 1 -C 6 )-alkyl, di-(C 1 -C4) alkoxy-(C 1 -Cs)-alkyl or (C1-C4)-alkylthio-(C1-C 6 )-alkyl, each of which is substituted by 5 n halogen atoms, a fully saturated 3- to 6-membered ring consisting of 3 to 5 carbon atoms and 1 to 3 heteroatoms from the group consiting of oxygen, sulfur and nitrogen which is substituted by n radicals from the group consisting of halogen, (C 1 -C4)-alkyl and WO 2010/069525 PCT/EP2009/008908 3 (C-C 4 )-alkoxy, (C 3 -C 6 )-cycloalkyl, phenyl, phenyl-(C-C4)-alkyl, heteroaryl, phenoxy-(C-C4)-alkyl or heteroaryloxy-(C-C4)-alkyl substituted by n radicals from the group consisting of halogen, (CI-C4)-alkyl and (Ci-C4)-alkoxy; 5 R 2 is (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 1 -C 4 )-alkoxy-(C 1 -Ce)-alkyl or di-(C-C4) alkoxy-(C-C 6 )-alkyl, each of which is substituted by n halogen atoms, or is (C 3 -C 6 )-cycloalkyl, phenyl or benzyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (C-C4)-alkoxy; 0 R 3 , R 4 and R' are each independently of one another (C-C 6 )-alkyl which is substituted by n halogen atoms, (C-C4)-alkoxy, N-(C-C 6 )-alkylamino, N,N-di-(C C 6 )-alkylamino, (C 1 -C4)-alkylthio, (C 2 -C 4 )-alkenyl or (C 3 -C 6 )-cycloalkylthio, or phenyl, benzyl, phenoxy or phenylthio which is substituted by n radicals from the 5 group consisting of halogen, (C-C 4 )-alkyl and (C-C 4 )-alkoxy; R 6 and R 7 are each independently of one another hydrogen, (C 1 -C 6 )-alkyl which is substituted by n halogen atoms, (C 3 -C 6 )-cycloalkyl, (C2-Cs) alkenyl, (Cl-C 6 )-alkoxy or (Ci-C4)-alkoxy-(C-C6)-alkyl, .0 phenyl or benzyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (C-C4)-alkoxy; or RW and R 7 together with the nitrogen atom to which they are attached form a 3- to 6-membered ring which contains 2 to 5 carbon atoms and 0 or 1 oxygen or sulfur atoms; .5 and a) X is hydrogen, (C-C 6 )-alkyl or (C 3 -C)-cycloalkyl; Y is halogen, cyano, nitro, halo-(C 1 -r)-alkyl, halo-(C,-C 6 )-alkoxy, (C 3 0 C6)-cycloalkyl, (Ci-Ce)-alkoxy or is phenyl which is substituted by n halogen atoms, Z is hydrogen, halogen, cyano, nitro, (CrC 6 )-alkyl, halo-(C-C6)-alkyl, WO 2010/069525 PCT/EP20091008908 4 halo-(C-C 6 )-alkoxy, (C 3 -Cs)-cycloalkyl or is phenyl which is substituted by n halogen atoms; or 5 b) X is halogen, cyano, nitro or is (CI-C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (Cr1C6) alkoxy or phenyl, each of which is substituted by n halogen atoms; Y and Z are each independently of one another hydrogen, halogen, cyano, nitro, (C3-C 6 )-cycloalkyl or are (C 1 C-0)-alkyl, (C-C 6 )-alkoxy or phenyl, each of 0 which is substituted by n halogen atoms. If G and/or B are hydrogen, the compounds of the formula (1) according to the invention can, depending on external conditions such as pH, solvent and temperature, be present in various tautomeric structures which are all embraced by 5 the general formula (1): OH O H O X N Y N H 0 XH O X H OH X 0 OH z -z N NyN y OH X 0 X In all the stuctures below, the substituents have, unless defined otherwise, the same 0 meaning as given above for the compounds of the formula (I). Compounds of the formula (1) according to the invention in which G is hydrogen can be prepared, for example, according to the method given in Scheme 1 by a base- WO 2010/069525 PCT/EP2009/008908 5 induced condensation reaction of compounds of the formula (11). Here, R 9 is (CrC) alkyl, in particular methyl or ethyl. Scheme 1 A A OH N yN B 0 X B O X 5 Scheme 1 A A OH N2 / N yN B 0 X B O X (II)(I Scheme 1 A A OH N N B 0 X B O X (11) (1) WO 20101069525 PCT/EP2009/008908 6 Scheme 1 A A OH N CO2R N B 0 X B O X (II) (1) The compounds of the formula (11) are novel and also form part of the subject matter of the present invention. They can be prepared, for example, according to the 5 method given in Scheme 1a by reaction of hydrazonocarboxylic acid derivatives with phenylacetic acid derivatives. Here, U is a leaving group introduced by reagents for activating carbonxylic acids, such as carbonyldiimidazole, carbonydiimides (such as, for example, dicyclohexylcarbodiimide), phosphorylating agents (such as, for example, POCl 3 , BOP-CI), halogenating agents such as, for example, thionyl 0 chloride, oxalyl chloride, phosgene or chloroformic esters. Such methods are also known to the person skilled in the art from W02007/119434 and the documents cited therein. Scheme 1a A A CO 2 R z N/ CO2R9 z + U N y N-H B X B 0 X (I I) 5 Compounds of the formula (II) can also be prepared, for example, according to the method shown in Scheme 1b, by the reaction, known to the person skliied in the art from Zh. Obs. Khim. 1992, 62, 2262, of hydrazides (Ila) with ketocarboxylic acids of the formula A-CO-C0 2 R 9 . 0 WO 2010/069525 PCT/EP20091008908 7 Scheme 1b A A9 H 2 N /7N /2 /7 CO2R + H2NNN C O2 Y B O y B 0 X (Ila) (II) The hydrazides of the formula (Ila) shown in Scheme 1b are novel and also form part of the subject matter of the present invention. They can be prepared, for example, by 5 reacting hydrazines of the formula B-NH-NH 2 with the phenylacetic acid derivatives shown in Schema 1a according to the method described in J. Org. Chem. 1980, 45, 3673. The hydrazides shown in Scheme 1a can be prepared from the ketocarboxylic acids A-CO-CO2R 9 shown in Scheme 1 b, which are known per se, for example according to the methods described in J. Med. Chem. 1985 (28), 1436. 0 The free phenylacetic acids required for preparing the phenylacetic acid derivatives shown in Schema 1a, i.e. those in which U is hydroxyl, are known or can be prepared by processes which are known per se, for example from WO 2005/075401, WO 2001/96277, WO 1996/35664 and WO 1996/25395. 5 However, certain phenylacetic acid derivatives can also be prepared using acetic ester enolates in the presence of palladium catalysts, for example formed from a palladium source (for example Pd 2 (dba) 3 or Pd(OAc) 2 ) and a ligand (for example (t Bu)3P, iMes*HCI or 2'-(N,N-dimethylamino)-2-(dicyclohexylphosphanyl)biphenyl) 0 (WO 2005/048710, J. Am. Chem. Soc 2002. 124,. 12557, J. Am. Chem. Soc 2003. 125, 11176 or J. Am. Chem. Soc. 2001, 123, 799). In addition, certain substitute aryl halides can be converted under copper catalysis into the corresponding substituted malonic esters (for example described in Org. Lett. 2002, 2, 269, WO 2004/108727), which can be converted by known methods into phenylacetic acids. 5 Compounds of the formula (1) according to the invention in which G is hydrogen can WO 2010/069525 PCTIEP2009/008908 8 also be prepared, for example, according to the method given in Scheme 2 by reacting compounds of the formula (1) in which G is R 8 with strong mineral bases such as sodium hydroxide or potassium hydroxide, or in concentrated mineral acids such as hydrobromic acid. Scheme 2 A OR' A OH N H 4 or ,, N 5 B O X B O X Compounds of the formula (1) according to the invention in which G is C(=0)R' can also be prepared, for example, by reactions known to the person skilled in the art of compounds of the formula (1) in which G is hydrogen with carbonyl halides of the 0 formula Hal-CO-R or with carboxylic anhydrides of the formula R 1 -CO-0-CO-R 1 Compounds of the formula (1) according to the invention in which G is C(=L)MR 2 can also be prepared, for example, by reactions known to the person skilled in the art of compounds of the formula (1) in which G is hydrogen with a) chloroformic esters or chloroformic thioesters of the formula R 2 -M-COOR 1 or b) with chloroformyl halides or 5 chloroformyl thiohalides. Compounds of the formula (1) according to the invention in which G is S0 2 R 3 can also be prepared, for example, by reactions known to the person skilled in the art of compounds of the formula (1) in which G is hydrogen with sulfonyl chlorides of the formula R 3 -S0 2 -CI. 0 Compounds of the formula (I) according to the invention in which G is P(=L)R 4 R 5 can also be prepared, for example, by reactions known to the person skilled in the art of compounds of the formula (1) in which G is hydrogen with phosphoryl chlorides of the formula Hal-P(=L)R 4 R 5 . Compounds of the formula (1) according to the invention in which G is E can also be WO 2010/069525 PCT/EP2009/008908 9 prepared, for example, by reactions known to the person skilled in the art of compounds of the formula (1) in which G is hydrogen with metal compounds of the formula Me(OR 0 )t or with amines. Here, Me is a mono- or divalent metal ion, preferably an alkali or alakline earth metal such as lithium, sodium, potassium, 5 magnesium or calcium. The index t is 1 or 2. An ammonium ion is the group NH 4 + or R 13 R 14 R 15 R 16 N+ in which R 13 , R 14 , R 15 and R 1 6 independently of one another are preferably (C-Cs)-alkyl or benzyl. Compounds of the formula (1) according to the invention in which G is C(=L)NR 6 R 7 can also be prepared, for example, by reactions known to the person skilled in the 0 art of compounds of the formula (1) in which G is hydrogen with isocyanates or isothiocyanates of the formula R 6 -N=C=L or with carbamoyl chlorides or thiocarbamoyl chlorides of the formula R 6 R 7 N-C(=L)CI. Compounds of the formula (I) according to the invention in which G is R 8 can also be prepared, for example, by reactions known to the person skilled in the art of 5 compounds of the formula (1) in which G is hydrogen with compounds of the formula R 8 -W in which W is chlorine, bromine, iodine or R 9 -S0 2 -O. R 9 is C-C 6 -alkyl, phenyl, tolyl or halo-C-C 6 -alkyl, preferably methyl, trifluoromethyl or tolyl. Compounds of the formula (1) according to the invention in which G is R 8 can also be prepared, for example, according to Scheme 3 by reactions known to the person .0 skilled in the art of compounds of the formula (111) with compounds of the formula (IV). Here, Z' is bromine or iodine and Q is a trialkyltin group, a magnesium halide group or, preferably, a boronic acid or an ester thereof. These reactions are usually carried out in the presence of a catalyst (for example a Pd salt or a Pd complex) and in the presence of a base (for example sodium carbonate, potassium phosphate). WO 2010/069525 PCT/EP2009/008908 10 Scheme 3 A OR 8 A ORB N OZ' + Q N QN BB O X (Il)(IV) (I) Depending on the nature of the substituents defined above, the compounds of the formula (I) have acidic or basic properties and may be also to form salts, if 5 appropriate also inner salts or adducts, with inorganic or organic acids or bases or with metal ions. If the compounds of the formula (I) carry amino groups, alkylamino groups or other groups which induced basic properties, these compounds may be reacted with acids to salts, or they are directly obtained as salts in the synthesis. Examples of inorganic acids are hydrohalic acids such as hydrofluoric acid, 0 hydrochloric acid, hydrobromic acid and hydroiodic acid, sulfuric acid, phosphoric acid and nitric acid, and acidic salts such as NaHSO 4 and KHSO 4 . Suitable organic acids are, for example, formic acid, carbonic acid and alkanoic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic 5 acid, cinnamic acid, oxalic acid, alkylsulfonic acids (sulfonic acids having straight chain or branched alkyl radicals of 1 to 20 carbon atoms), arylsulfonic acids or -disulfonic acids (aromatic radicals such as phenyl and naphthyl which carry one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), 0 arylphosphonic acids or - diphosphonic acids (aromatic radicals such as phenyl and naphthyl which carry one or two phosphonic acid radicals), where the alkyl or aryl radicals may carry further substituents, for example p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc. Suitable metal ions are in particular the ions of the elements of the second main 5 group, in particular calcium and magnesium, the third and fourth main group, in WO 2010/069525 PCT/EP2009/008908 11 particular aluminum, tin and lead, and also of the first to eigth transition group, in particular chromium, manganese, iron, cobalt, nickel, copper, zinc and others. Particular preference is given to the metal ions of the elements of the fourth period. Here, the metals may be present in the different valencies that they can assume. 5 If the compounds of the formula (1) carry hydroxyl groups, carboxyl groups or other groups which induce acidic properties, these compounds can be reacted with bases to salts. Suitable bases are, for example, hydroxides, carbonates, bicarbonates of the alkali and alkaline earth metals, in particular those of sodium, potassium, magnesium and 0 calcium, furthermore ammonia, primary, secondary and tertiary amins having (C C 4 )-alkyl groups, mono-, di- and trialkanolamines of (C-C4)-alkanols, choline and also chlorocholine. Halogen is fluorine, chlorine, bromine and iodine. 5 A metal ion equivalent is a metal ion having a positive charge, such as Na*, K*, (Mg 2 +) 1 t 2 , (Ca 2 +) 1 / 2 , MgH*, CaH*, (A 3 *) 113 (Fe 2 +),/ 2 or (Fe 3 +) 1 3 . Alkyl is a saturated straight-chain or branched hydrocarbon radical having 1 to 8 .0 carbon atoms, for example C-C 6 -alkyl such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2 methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1 dimethylpropyl, 1,2-dimethylpropyl,1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4 methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2 !5 dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1 -ethylbutyl, 2-ethylbutyl, 1,1,2 trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methyl propyl. Haloalkyl is a straight-chain or branched alkyl group having 1 to 8 carbon atoms (as 0 mentioned above), where some or all of the hydrogen atoms in this group may be replaced by halogen atoms, for example C-C 2 -haloalkyl such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoro- WO 2010/069525 PCT/EP2009/008908 12 methyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2 chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2 trichloroethyl, pentafluoroethyl and 1,1,1-trifluoroprop-2-yl. 5 Alkenyl is an unsaturated straight-chain or branched hydrocarbon radical having 2 to 8 carbon atoms and a double bond in any position, for example C 2 -C 6 -alkenyl such as ethenyl, I -propenyl, 2-propenyl, 1 -methylethenyl, 1 -butenyl, 2-butenyl, 3-butenyl, 1-methyl-I -propenyl, 2-methyl-1 -propenyl, 1 -methyl-2-propenyl, 2-methyl-2-propenyl, 0 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1 -butenyl, 2-methyl-1 butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2 butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2 propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, I ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1 5 pentenyl, 2-methyl-1 -pentenyl, 3-methyl-I -pentenyl, 4-methyl-1 -pentenyl, 1 -methyl-2 pentenyl, 2-methyl-2-pentenyl, 3-m ethyl-2-pente nyl, 4-methyl-2-pentenyl, 1-methyl-3 pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4 pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1 dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-I-butenyl, 1,2-dimethyl-2 0 butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-i-butenyl, 1,3-dimethyl-2-butenyl, 1,3 dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2 butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1 ethyl-1 -butenyl, 1 -ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2 butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-I -methyl-2-propenyl, 1 5 ethyl-2-m ethyl-1 -propenyl and I -ethyl-2-methyl-2-propenyl. Alkoxy'is a saturated straight-chain or branched alkoxy radical having 1 to 8 carbon atoms, for example C-C 6 -alkoxy such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1 0 methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy,1-methylpentoxy, 2 methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2- WO 2010/069525 PCT/EP2009/008908 13 dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3 dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethyl propoxy, 1-ethyl-1 -methylpropoxy and I -ethyl-2-methylpropoxy; Haloalkoxy is a straight-chain or branched alkoxy group having 1 to 8 carbon atoms 5 (as mentioned above), where some or all of the hydrogen atoms in this group may be replaced by halogen atoms as mentioned above, for example C1-C 2 -haloalkoxy such as chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1 0 fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2 fluoroethoxy, 2-chlor-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2 trichloroethoxy, pentafluoroethoxy and 1,1,1 -trifluoroprop-2-oxy. Alkylthio is a saturated straight-chain or branched alkylthio radical having 1 to 8 5 carbon atoms, for example C-C 6 -alkylthio such as methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methyl-propylthio, 2-methylpropylthio, 1,11 dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2-di-methylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-di methylpropylthio, 1 -methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4 0 methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethyl-butylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-d imethylbutylthio, 1 -ethylbutylthio, 2 ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl-1 methylpropylthio and 1-ethyl-2-methylpropylthio; 5 Haloalkylthio is a straight-chain or branched alkylthio group having I to 8 carbon atoms (as mentioned above), where some or all of the hydrogen atoms in this group may be replaced by halogen atoms as mentioned above, for example C 1 -C 2 haloalkylthio such as chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, 0 chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 1 chloroethylthio, 1-bromoethylthio, 1-fluoroethylthio, 2-fluoroethylthio, 2,2 difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-di- WO 2010/069525 PCT/EP2009/008908 14 fluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio, pentafluoroethylthio and 1,1,1-trifluoroprop-2-ylthio. Heteroaryl is 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3 5 isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 3-isothiazolyl, 4-isothiazolyl, 5-isothiazolyl, 1 pyrazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2 thiazolyl, 4-thiazolyl, 5-thiazolyl, 1-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yi, 1,2,4-triazol-1-yl, 1,2,4-triazol-3-yl, 1,2,4 0 triazol-4-yl, 1,2,4-triazol-5-yI, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,2,3-triazol-4-yl, tetrazol-1-yl, tetrazol-2-yl, tetrazol-5-yl, indol-1-yl, indol-2-yl, indol-3-yl, isoindol-1-yl, isoindol-2-yl, benzofur-2-yl, benzothiophen-2-yl, benzofur-3-yl, benzothiophen-3-yl, benzoxazol-2-yl, benzothiazol-2-yl, benzimidazol-2-yl, indazol-1-yl, indazol-2-yl, indazol-3-yl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2 S pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl, 1,2,4-triazin-3 yl, 1,2,4-triazin-5-yl or 1,2,4-triazin-6-yl. This heteroaryl is in each case unsubstituted or mono- or polysubstituted by identical or different radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxyl, mercapto, amino, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclopropyl, 0 1-chlorocyclopropyl, vinyl, ethynyl, methoxy, ethoxy, isopropoxy, methylthio, ethylthio, trifluoromethylthio, chlorodifluoromethyl, dichlorofluoromethyl, chlorofluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluorethyl, trifluoromethoxy, trifluoromethylthio, 2,2,2-trifluoroethoxy, 2,2-dichloro-2-fluoroethyl, 2,2-difluoro-2-chloroethyl, 2-chloro-2 5 fluoroethyl, 2,2,2-trichloroethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2 methoxyethoxy, acetyl, propionyl, methoxycarbonyl, ethoxycarbonyl, N-methylamino, N,N-dimethylamino, N-ethylamino, N,N-diethYlamino, aminocarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, dimethylcarbamoylamino, methoxycarbonylamino, methoxycarbonyloxy, ethoxycarbonylamino, 0 ethoxycarbonyloxy, methylsulfamoyl, dimethylsulfamoyl, phenyl or phenoxy. Depending inter alia on the nature of the substituents, the compounds of the formula WO 2010/069525 PCT/EP2009/008908 15 (1) can be present as geometrical and/or optical isomers or isomer mixtures of varying composition which, if appropriate, can be separated in a customary manner. The present invention provides both the pure isomers and the isomer mixtures, their preparation and use and compositions comprising them. However, hereinbelow, for 5 the sake of simplicity, compounds of the formula (1) are always referred to, although this is meant to include both the pure compounds and, if appropriate, mixtures having varying proportions of isomeric compounds. If a group is polysubstituted by radicals, this is to be understood as meaning that this 0 group is substituted by one or more identical or different radicals from the radicals mentioned. Preference is given to compounds of the general formulae (I-a), (I-b), (I-c), (1-d), (I-e), (1-f) and (1-g): 5 A OH A O-C(=O)R z z N(1-a) N N ~ (I-b) B O X B O X A O-C(=L)MR 2 A O-SO2R N (l-c) N (1-d) B O X B O X A O--P(=L)R 4 R A O-C(=L)NRI R e) (I-f) B O X B O X WO 2010/069525 PCT/EP2009/008908 16 A O-E I x ~(I-g) Preference is also given to compounds of the general formula (1) in which A is (C 3 -C 6 )-cycloalkyl, (C3-C 6 )-cycloalkyl-(C-C 6 )-alkyl, benzyl, halophenyl-(C 5 C 8 )-alkyl or is (C-C 6 )-alkyl which is substituted by n halogen atoms; B is (C 3 -Ce)-cycloalkyl, (C3-C6)-cycloalkyl-(Cl-C 6 )-alkyl, benzyl, halophenyl-(C C 6 )-alkyl or is (C-C 6 )-alkyl which is substituted by n halogen atoms; 0 m is 0, 1, 2 or 3; n is 0, 1, 2 or 3, with the proviso that m and n are not both 0; G is hydrogen, C(=O)R 1 , C(=L)MR 2 , S0 2 R 3 , P(=L)R 4 R 5 , C(=L)NR 6 R, or E; 5 E is Nat, K*, (Mg2+) 1 / 2 , (Ca2+) 1 / 2 , R1R1R5R16N* or NH 4 *; R , R 4, R and R are independently of one another (C-C 6 )-alkyl or benzyl; 0 L is oxygen; M is oxygen; R1 is (C-C 6 )-alkyl which is substituted by n halogen atoms or is (C 3 -C 6 ) 5 cycloalkyl, phenyl or phenyl-(C-C 4 )-alkyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (Ci-C4)-alkoxy; WO 2010/069525 PCT/EP2009/008908 17 R 2 is (C-C 6 )-alkyl which is substituted by n halogen atoms or is (C3-Ce) cycloalkyl, phenyl or benzyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C 4 )-alkyl and (C-C4)-alkoxy; 5 R 3 , R 4 and R 5 are each independently of one another (CrCs)-alkyl which is substituted by n halogen atoms or are phenyl or benzyl which are substituted by n radicals from the group consisting of halogen, (Ci-C4)-alkyl and (C-C4)-alkoxy; R 6 and R 7 are each independently of one another hydrogen, (C-C 6 )-alkyl which is 0 substituted by n halogen atoms or phenyl or benzyl which are substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (C-C4)-alkoxy; and 5 a) X is hydrogen, methyl, ethyl or cyclopropyl; Y is halogen, cyano, nitro, halo-(C-Ce)-alkyl, halo-(C 1 -C 6 )-alkoxy, (C3 C6)-cycloalkyl, (C-Ce)-alkoxy or phenyl which is substituted by n halogen atoms, Z is hydrogen, halogen, halo-(C-C 6 )-alkyl, halo-(C-C 6 )-alkoxy, (C3-Ce) o cycloalkyl or phenyl which is substituted by n halogen atoms, or b) X is halogen, cyano, nitro, halo-(C-C 6 )-alkyl, halo-(C-C 6 )-alkoxy, (Cl 5 Ce)-alkoxy or (C3-C 6 )-cycloalkyl; Y is hydrogen, halogen, cyano, nitro, (C3-C 6 )-cycloalkyl, is (C 1 -C 6 )-alkyl, (C-Cs)-alkoxy or phenyl, each of which is substituted by n halogen atoms; Z is hydrogen, halogen, cyano, nitro, (C 3 -C 6 )-cycloalkyl or is (C-Cs)-alkyl, 0 (C 1 -r)-alkoxy or phenyl, each of which is substituted by n halogen atoms. WO 20101069525 PCT/EP2009/008908 18 Particular preference is given to compounds of the general formula (1) in which A is cyclopropyl, cyclopropylmethyl, benzyl, 2-chlorophenylmethyl, 3 5 ch lorophenylmethyl or 4-ch lorophenylmethyl; B is hydrogen, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, cyclopropyl, cyclopropylmethyl, benzyl, 2-chlorophenylmethyl, 3-chlorophenylmethyl or 4-chloro phenylmethyl; 0 G is hydrogen, C(=O)R 1 , C(=L)MR 2 , S0 2 R 3 , P(=L)R 4 R, C(=L)NR 6 R 7 , E or R8; E is Na, K*, (Mg2+) 1 / 2 , (Ca 2 + ) 112 , (CH 3 ) 4 N* or NH 4 *; 5 L is oxygen; M is oxygen; R 1 is (C1-C 6 )-alkyl or (C3-C 6 )-cycloalkyl; 0 R 2 is (C1-Cs)-alkyl, (C 3 -Ce)-cycloalkyl or benzyl; R 3 , R 4 and R 5 are each independently of one another (C 1 -C 6 )-alkyl, phenyl or benzyl; 5 R 6 and R 7 are each independently of one another hydrogen, (C-C 6 )-alkyl, phenyl or benzyl; and 0 a) X is hydrogen, methyl or ethyl; Y is fluorine, bromine, chlorine, iodine, cyano, nitro, cyclopropyl, methoxy, ethoxy, trifluoromethyl or trifluoromethoxy, phenyl or halophenyl; WO 2010/069525 PCT/EP2009/008908 19 Z is hydrogen, fluorine, bromine, chlorine, iodine, methyl, ethyl, methoxy, ethoxy, trifluoromethyl or cyclopropyl; or 5 b) X is fluorine, bromine, chlorine, iodine, cyano, nitro, methoxy, ethoxy, trifluoromethyl, trifluoromethoxy or cyclopropyl; Y is hydrogen, fluorine, bromine, chlorine, iodine, methyl, ethyl, methoxy, ethoxy, trifle u orom ethyl, trifluoromethoxy or cyclopropyl; Z is hydrogen, fluorine, bromine, chlorine, iodine, methyl, ethyl, methoxy, 0 ethoxy, trifluoromethyl, trifluoromethoxy, cyclopropyl, chlorophenyl or fluorophenyl. Very particular preference is given to the compounds of the general formula (1) listed in Tables 1 to 94 which can be obtained analogously to the methods mentioned 5 here. The abbreviations used are defined below: Bz = benzyl c-Pr = cyclopropyl Et = ethyl i-Bu = isobutyl t-Bu = tertiary butyl i-Pr = isopropyl Me = methyl Ph = phenyl c = cyclo Table 1: Compounds of the general formula (1) according to the invention in .0 which G is hydrogen, A is methyl and B is cyclopropylmethyl. H3C OH NI 0 x No. X Y Z 1 F H H 2 CI H H WO 2010/069525 PCTIEP2009/008908 20 No. X Y Z 3 Br H H 4 1 H H 5 OMe H H 6 EtO H H 7 CF 3 H H 8 CN H H 9 NO 2 H H 10 OCF 3 H H 11 H 3-CF 3 H 12 H 3-Me H 13 H 3-F H 14 H 3-Cl H 15 H 3-CN H 16 H 3-Br H 17 H 3-1 H 18 H 3-NO 2 H 19 H 3-OCF 3 H 20 H 3-OMe H 21 H 3-EtO H 22 H 4-CF 3 H 23 H 4-Me H 24 H 4-F H 25 H 4-Cl H 26 H 4-CN H 27 H 4-Br H 28 H 4-1 H 29 H 4-NO 2 H 30 H 4-OCF 3 H 31 H 4-OMe H 32 H 4-EtO H 33 Cl 4-Cl H 34 H 3-Cl 4-Cl 35 Br 4-Cl H 36 CI H 6-Cl 37 CI H 6-F 38 F H 6-F WO 2010/069525 PCT/EP2009/008908 21 No. X Y Z 39 Me 4-Cl H 40 Me 4-Br H 41 Me 4-1 H 42 CI 4-Cl 6-Cl 43 Cl 6-Me 4-Br 44 Cl 6-Me 4-Cl 45 Br 6-Me 4-Cl 46 Br 6-Me 4-Br 47 OMe 6-Me 4-Cl 48 EtO 6-Me 4-Cl 49 Cl 6-Me 4-Br 50 Cl 6-Et 4-Cl 51 Br 6-Et 4-Cl 52 Br 6-Et 4-Br 53 OMe 6-Et 4-Cl 54 EtO 6-Et 4-Cl 55 Br 4-Me 6-Br 56 Cl 4-Me 6-Cl 57 OMe 4-Me 6-Me 58 EtO 4-Me 6-Me 59 OMe 6-Et 4-Me 60 EtO 6-Et 4-Me 61 Cl 4-Me 6-Et 62 Et 6-Et 4-Cl 63 Et 6-Me 4-Br 64 Et 6-Et 4-Br 65 Et 6-Me 4-Cl 66 Et 6-Me 4-Br 67 OMe 4-Me 6-Cl 6p EtO 4-Me 6-Cl 69 H 4-Me 70 6-Me H 71 I 6-Et H 72 I 4-Me 6-Me 73 I 6-Et 4-Me 74 6-Me 4-Cl WO 2010/069525 PCT/EP2009/008908 22 No. X Y Z 75 6-Et 6-Cl 76 I 6-Cl 4-Me 77 Me 4-1 H 78 Et 4-1 H 79 Et 4-1 6-Me 80 Et 4-1 6-Et 81 CI 6-Me 4-1 82 CI 6-Et 4-1 83 c-Pr H H 84 c-Pr 4-Me H 85 c-Pr H 6-Me 86 c-Pr 6-Et H 87 c-Pr 4-Me 6-Me 88 c-Pr 6-Et 4-Me 89 c-Pr 4-Me 6-Cl 90 c-Pr 6-Et 4-Cl 91 c-Pr 4-Cl 6-Me 92 Me 4-c-Pr H 93 Et 4-c-Pr H 94 Me 4-c-Pr 6-Me 95 Et 4-c-Pr 6-Me 96 Et 4-c-Pr 6-Et 97 Cl 6-Me 4-c-Pr 98 Cl 6-Et 4-c-Pr 99 Et 6-Et 4-1 100 CI 6-F 3-Me 101 F 6-F 3-F 102 EtO 6-F 3-F 103 F 6-F 3-EtO 104 F H 5-Cl 105 H 3-CF 3 5-CF 3 106 Me 4-OCF 3 H 107 OCF 3 4-Me H 108 OCF 3 5-Me H 109 OCF 3 6-Me H 110 OCF 3 6-Et H WO 2010/069525 PCT/EP2009/008908 23 No. X Y Z 111 Me 5-OCF 3 H 112 Me 3-OCF 3 6-Me 113 Br 4-OCF 3 6-CI 114 Br 4-OCF 3 6-Br 115 OMe 4-OCF 3 6-Br 116 OMe 4-OCF 3 6-CI 117 CI 4-OCF 3 6-CI 118 OMe 4-OCF 3 6-CI 119 OMe 4-OCF 3 6-Br 120 Me 4-OCF 3 6-Me 121 Cl 4-OCF 3 6-Me 122 OCF 3 6-CI 4-Br 123 OCF 3 6-Me 4-Me 124 OCF 3 6-OMe 4-CI 125 OCF 3 6-Cl 4-Me 126 CI 5-OCF 3 H 127 Br 5-OCF 3 H 128 OCF 3 6-Et 4-CI 129 Br 4-CI 6-Br 130 Br 4-Cl 6-CI 131 Br 4-Me 6-Cl 132 Cl 3-Me 6-CI 133 Cl 3-F 6-F 134 F 3-Me 6-F 135 F 4-OMe 6-F 136 F 3-OMe 6-F 137 Cl 3-CI 6-F 138 Cl 4-Et 6-Cl 139 Cl 4-Et 6-Br 140 CI 3-Br 6-CI 141 CI 4-CF 3 6-F 142 CI 4-CF 3 6-CI 143 CI 3-Cl 6-CI 144 CI 3-CF 3 6-CI 145 F 3-F 6-NO 2 146 F 4-NO 2 6-F WO 2010/069525 PCT/EP2009/008908 24 No. X Y Z 147 CI 4-CF 3 6-NO 2 148 Br 6-NO 2 H 149 F 4-CF 3 6-F 150 Br 6-Br H 151 CI 3-OMe 6-F 152 F 3-OMe 6-Cl 153 F 4-Cl 6-F 154 F 4-Br 6-F 155 F 4-Br 6-Br 156 CI 4-Br 6-Cl 157 F 4-EtO 6-F 158 F 3-Cl 6-F 159 CI 3-Cl 6-Br 160 F 3-F 6-Cl 161 F 3-F 6-Br 162 F 3-F 6-1 163 CI 6-CF 3 H 164 Cl 3-Cl 6-CF 3 165 F 3-Cl 6-CF 3 166 CI 3-CF 3 6-Cl 167 c-Pr 4-Cl 6-Cl WO 2010/069525 PCT/EP2009/008908 25 Table 2: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is cyclopropylmethyl and X, Y and Z have the meanings given in Table 1. CH3 OH N 0 x 5 Table 3: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is cyclopropylmethyl and X, Y and Z have the meanings given in Table 1. CH3 OH N O x 0 Table 4: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is cyclopropylmethyl and X, Y and Z have the meanings given in Table 1. H 3C H 3C '-N OH z N Ny. 5 Table 5: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is cyclopropylmethyl and X, WO 2010/069525 PCT/EP2009/008908 26 Y and Z have the meanings given in Table 1. CH3 H3C OH N z /N ~~ x y Table 6: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is cyclobutyl and X, Y and Z 5 have the meanings given in Table 1. H 3 C OH N - z do x Table 7: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is cyclobutyl and X, Y and Z have the meanings given in Table 1. CH 3 OH N z N --- y Table 8: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is cyclobutyl and X, Y and Z have the meanings given in Table 1. WO 20101069525 PCT/EP2009/008908 27 Table 9: Compounds of the general formula (I) according to the invention in which 0 is hydrogen, A is isobutyl and B is cyclobutyl and X, Y and Z have the meanings given in Table 1. 3C OH N 5 Table 10: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is cyclobutyl and X, Y and Z have the meanings given in Table 1. 3C CH3 HsC OH O x O Table 11: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 2,2-difluoroethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCTIEP20091008908 28 H3C OH N ' F N -y P 0 x F Table 12: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 2,2-difluoroethyl and X, Y and Z have the meanings given in Table 1. H3C OH F N 0 Y 5 F Table 13: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is B 2,2-difluoroethyl and X, Y and Z have the meanings given in Table 1. OH HN F 0 Table 14: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is 2,2-difluoroethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 29 H 3C H 3C OHz F N N y F Table 15: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 2,2-difluoroethyl and X, Y and Z have the meanings given in Table 1. CH3 H 3C OH z F N N-y O x 5 F Table 16: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 2,2,2-trifluoroethyl and X, Y and Z have the meanings given in Table 1. H 3C OH F F N O x F 0 Table 17: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is ethyl and B is 2,2,2-trifluoroethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 30 CH3 OH F F N O x F Table 18: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is 2,2,2-trifluoroethyl and X, Y and Z have the meanings given in Table 1. OH H FN O x 5 F Table 19: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is 2,2,2-trifluoroethyl and X, Y and Z have the meanings given in Table 1. H3C H C OHz F F N y F 0 Table 20: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 2,2,2-trifluoroethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCTIEP2009/008908 31 CH3 H 3C OH N z F F /N y F Table 21: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is benzyl and X, Y and Z have the meanings given in Table 1. H3C OH N 5 N O 5 a Table 22: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is benzyl and X, Y and Z have the meanings given in Table 1. H 3C OH N/ z 3Y N OX 0 Table 23: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is benzyl and X, Y and Z have the meanings piven in Table 1. 3OH Ny WO 2010/069525 PCTJEP20091008908 32 Table 24: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is benzyl and X, Y and Z have the meanings given in Table 1. HaC OH H3 C Nz N O X 5 Table 25: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is benzyl and X, Y and Z have the meanings given in Table 1. CH3 H3C OH N/ N O X Table 26: Compounds of the general formula (1) according to the invention in 0 which G is hydrogen, A is methyl and B is 2-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. H3C OH 0 XI Table 27: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B 2-chlorophenylmethyl and X, Y 5 and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 33 Table 28: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is 2-chlorphenylmethyl and X, Y and Z have the meanings given in Table 1. HCCI NZ Ny 3Y 0 x 5 Table 29: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is 2-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. H 3 C CH 3 OH CI N' z o x O Table 30: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 2-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. >CH3 Hac OH C Nz O X WO 20101069525 PCT/EP2009/008908 34 Table 31: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 3-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. H 3 c OH z ci N 0 X 5 Table 32: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 3-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. CH OH C O1 X Table 33: Compounds of the general formula (1) according to the invention in 0 which G is hydrogen, A is propyl and B is 3-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. /CH, OH C x1N Table 34: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is 3-chlorophenylmethyl and 5 X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 35 H3C CH 3 OH Table 35: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 3-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. CH3 H3C OH 5 c0 x 5 t Table 36: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 4-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. H 3C OH CI O X 0 Table 37: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 4-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCTIEP2009/008908 36 CH3 OH N z CI /N y Table 38: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is 4-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. H3C OH N/ z 5IC N O 5 Table 39: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is 4-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. H3C OH H3C Nz CI N O 0 Table 40: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 4-chlorophenylmethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 37 CH H 3C OH N/z ci N Oy Table 41: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 2-phenylethyl and X, Y and Z have the meanings given in Table 1. H3C OH (: N z N --- y 5 0 X Table 42: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 2-phenylethyl and X, Y and Z have the meanings given in Table 1. H 3C OH N/ z N --- y 0 x 0 Table 43: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is 2-phenylethyl and X, Y and Z have the meanings given in Table 1. oH OH N/ Z N -~ y 0 x Table 44: Compounds of the general formula (1) according to the invention in WO 2010/069525 PCT/EP2009/008908 38 which G is hydrogen, A is isobutyl and B is 2-phenylethyl and X, Y and Z have the meanings given in Table 1. HCH CH3 OH O x Table 45: Compounds of the general formula (1) according to the invention in 5 which G is hydrogen, A is isopropyl and B is 2-phenylethyl and X, Y and Z have the meanings given in Table 1. H 3C OH 0 x Table 46: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 2-(2-chlorophenyl)ethyl and 0 X, Y and Z have the meanings given in Table 1. H 3C OH N Y CI O x Table 47: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 2-(2-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. WO 20101069525 PCTIEP2009/008908 39 H3C OH N Z Cl 0 x Table 48: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 2-(2-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. CH 3 OH N/ Z N -y 5 C1 O x Table 49: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isobutyl and B is 2-(2-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. H3C CH 3 O Table 50: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 2-(2-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. CH HaC OH N/ Z N -- ~ y ClC OHx WO 2010/069525 PCT/EP2009/008908 40 Table 51: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is methyl and B is 2-(4-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. CI H3C ' OH NY 5 0 X Table 52: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is ethyl and B is 2-(4-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. CI HaC OH N O 0 Table 53: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is propyl and B is 2-(4-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. CH C1 OH \ / N y 0 x Table 54: Compounds of he general formula (F) according to the invention in 5 which G is hydrogen, A is isobutyl and B is 2-(4-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. WO 20101069525 PCT/EP2009/008908 41 H3C CH, Cl OH / / N y 0 X Table 55: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is isopropyl and B is 2-(4-chlorophenyl)ethyl and X, Y and Z have the meanings given in Table 1. CH3 CI H3C OH OH z N -y 5 O X Table 56: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is cyclopropyl and B is 4-methyl and X, Y and Z have the meanings given in Table 1. OH N z N -- y H3C O X 0 Table 57: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is cyclopropyl and B is ethyl and X, Y and Z have the meanings given in Tablel 1. WO 2010/069525 PCT/EP2009/008908 42 OHz H3 N yY Table 58: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is cyclopropyl and B is isobutyl and X, Y and Z have the meanings given in Table 1. OH H 3C N y 5 H 3 C Table 59: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is cyclopentyl and B is methyl and X, Y and Z have the meanings given in Table 1. GOH N H3C O X 0 Table 60: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is cyclopentyl and B is ethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCTIEP20091008908 43 OH Table 61: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is cyclopentyl and B is isobutyl and X, Y and Z have the meanings given in Table 1. OH N z H 3C N y O x 5 H 3 C Table 62: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is benzyl and B is methyl and X, Y and Z have the meanings given in Table 1. OHz N/ y H 3C O X 0 Table 63: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is benzyl and B is ethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 44 OH N H 3C O X Table 64: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is benzyl and B is isobutyl and X, Y and Z have the meanings given in Table 1. / OH N Hz H 3C N---- y Ox 5 H 3C Table 65: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 4-fluorobenzyl and B is methyl and X, Y and Z have the meanings given in Table 1. F OHz Ny H3C O X 0 Table 66: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 4-fluorobenzyl and B is ethyl and X, Y and Z have the meanings given in Table 1.- WO 2010/069525 PCT/EP2009/008908 45 IF OHz N y H 3 C- Table 67: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 4-fluorobenzyl and B is isobutyl and X, Y and Z have the meanings given in Table 1. F- OH N z H3C N ~y 5 H 3 C Table 68: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-fluorobenzyl and B is methyl and X, Y and Z have the meanings given in Table 1. F OH N/ H N H3C 0 X 0 Table 69: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-fluorobenzyl and B is ethyl and X, Y and Z have the meanings given in Table 1. WO 20101069525 PCT/EP2009/008908 46 F OH H3 C- O X Table 70: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-fluorobenzyl and B is isobutyl and X, Y and Z have the meanings given in Table 1. F OH H3C N 5 H 3 C Table 71: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 3-fluorobenzyl and B is methyl and X, Y and Z have the meanings given in Table 1. F OH N/ H 3C O X 0 Table 72: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is 3-fluorobenzyl and B is ethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 47 F Table 73: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 3-fluorobenzyl and B is isobutyl and X, Y and Z have the meanings given in Table 1. F OH N z H3N ~~ y 5 H 3 C Table 74: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-phenylethyl and B is 4-methyl and X, Y and Z have the meanings given in Table 1. OH N/ z H c O o Table 75: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-phenylethyl and B is 4-ethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 48 OH N/ N -y Hc 0 X Table 76: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-phenylethyl and B is 4-isobutyl and X, Y and Z have the meanings given in Table 1. OH OH N z H 3 C N y O x 5 H 3 C Table 77: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-(4-chlorophenyl)ethyl and B is 4-methyl and X, Y and Z have the meanings given in Table 1. CI OH N/ H 3C O X 0 Table 78: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-(4-chlorophenyl)ethyl and B is 4-ethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 49 CI OH N/ z N y Table 79: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-(4-chlorophenyl)ethyl and B is 4-isobutyl and X, Y and Z have the meanings given in Table 1. C1 OH N z H C N - 3o x 5 H 3 C Table 80: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-(2-chlorophenyl)ethyl and B is 4-methyl and X, Y and Z have the meanings given in Table 1. Cl OH N z / N ~ y a H 3C O X 0 Table 81: Compounds of the general formula (1) according to the invention in WO 2010/069525 PCT/EP2009/008908 50 which G is hydrogen, A is 2-(2-chlorophenyl)ethyl and B is 4-ethyl and X, Y and Z have the meanings given in Table 1. CI OH N z N y 5 Table 82: Compounds of the general formula (1) according to the invention in which G is hydrogen, A 2-(4-chlorophenyl)ethyl and B is 4-isobutyl and X, Y and Z have the meanings given in Table 1. CI OH N Z HC N ---- y O x H 3 C Table 83: Compounds of the general formula (1) according to the invention in 0 which G is hydrogen, A is 2-(3-chlorophenyl)ethyl and B is 4-methyl and X, Y and Z have the meanings given in Table 1. CI OH N z /N y H 3 C O X WO 2010/069525 PCT/EP2009/008908 51 Table 84: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is 2-(3-chlorophenyl)ethyl and B is 4-ethyl and X, Y and Z have the meanings given in Table 1. Cl OH N Z N y H3C 0 X 5 Table 85: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is 2-(3-chlorophenyl)ethyl and B is 4-isobutyl and X, Y and Z have the meanings given in Table 1. Cl OH N/ Z H 3 C N Y o x H 3 C Table 86: Compounds of the general formula (I) according to the invention in 0 which G is hydrogen, A is cyclopropyl and B is cyclopropylmethyl and X, Y and Z have the meanings given in Table 1. T OH N/ z N 0 x Table 87: Compounds of the general formula (1) according to the invention in WO 2010/069525 PCT1EP20091008908 52 which G is hydrogen, A is cyclopropyl and B is 2,2-difluoroethyl and X, Y and Z have the meanings given in Table 1. OH F Ny 0 x F Table 88: Compounds of the general formula (1) according to the invention in 5 which G is hydrogen, A is cyclopropyl and B is 4-2,2,2-trifluoroethyl and X, Y and Z have the meanings given in Table 1. OH F N F F /N x F Table 89: Compounds of the general formula (1) according to the invention in which G is hydrogen, A is cyclopropyl and B is methyl and X, Y and Z 0 have the meanings given in Table 1. OH N 4 Table 90: Compounds of the general formula (I) according to the invention in which G is hydrogen, A is cyclopropyl and B is ethyl and X, Y and Z have the meanings given in Table 1. WO 2010/069525 PCT/EP2009/008908 53 OH H 3 C 0 X Very particular preference is also given to compounds in Tables 1 to 32 listed above in which G is in each case C(=O)R, C(=L)LR 2 , S0 2 R 3 , P(=L)R 4 R 5 , C(=L)NR 6 R 7 , E or 5 R 8 . Collections of compounds of the formula (I) and/or their salts which can be synthesized in accordance with the abovementioned reactions can also be prepared in a parallelized manner, which can be effected manually or in a partly or fully 0 automated manner. Here, it is possible for example to automate the procedure of the reaction, the work-up or the purification of the products or intermediates. In total, this is understood as meaning a procedure as described for example by D. Tiebes in Combinatorial Chemistry - Synthesis, Analysis, Screening (Editor Ganther Jung), Wiley 1999, on pages 1 to 34. 5 A number of commercially available apparatuses can be used for the parallelized reaction procedure and work-up, for example Calpyso reaction blocks from Barnstead International, Dubuque, Iowa 52004-0797, USA, or reaction stations from Radleys, Shirehill, Saffron Walden, Essex, CB 11 3AZ, England or MultiPROBE 0 Automated Workstations from Perkin Elmar, Waltham, Massachusetts 02451, USA. Chromatographic apparatuses, for example from ISCO, Inc., 4700 Superior Street, Lincoln, NE 68504, USA, are available, inter alia, for the parallelized purification of compounds of the formula (1) and their salts or of intermediates generated in the course of the preparation. 5 The apparatuses listed lead to a modular procedure in which the individual passes are automated, but manual operations must be carried out between the passes. This WO 2010/069525 PCT/EP2009/008908 54 can be circumvented by the use of partly or fully integrated automation systems, where the relevant automation modules are operated by, for example, robots. Such automation systems can be obtained for example from Caliper, Hopkinton, MA 01748, USA. 5 The performance of individual, or a plurality of, synthesis steps can be aided by the use of polymer-supported reagents/scavenger resins. The specialist literature describes a series of experimental protocols, for example in ChemFiles, Vol. 4, No. 1, Polymer-Supported Scavengers and Reagents for Solution-Phase Synthesis 0 (Sigma-Aldrich). Besides the methods described herein, the preparation of compounds of the formula (1) and their salts can be effected fully or in part by solid-phase-supported methods. For this purpose, individual intermediates, or all intermediates, of the synthesis or of 5 a synthesis adapted to the relevant procedure are bound to a synthesis resin. Solid phase-supported synthesis methods are described sufficiently in the specialist literature, for example Barry A. Bunin in "The Combinatorial Index", Academic Press, 1998 and Combinatorial Chemistry - Synthesis, Analysis, Screening (Editor Gunther Jung), Wiley, 1999. The use of solid-phase-supported synthesis methods permits a 0 series of protocols known from the literature, which, again, can be carried out manually or in an automated manner. For example, the reactions can be carried out by means of IRORI technology in microreactors from Nexus Biosystems, 12140 Community Road, Poway, CA92064, USA. 5 Carrying out individual or a plurality of synthesis steps, both on a solid and in the liquid phase, can be aided by the use of microwave technology. A series of experimental protocols are described in the specialist literature, for example in Microwaves in Organic and Medicinal Chemistry (Editors C. 0. Kappe and A. Stadler), Wiley, 2005. 0 The preparation in accordance with the processes described herein generates compounds of the formula (1) and their salts in the form of substance collections, WO 2010/069525 PCTIEP2009/008908 55 which are referred to as libraries. The present invention also relates to libraries which comprise at least two compounds of the formula (1) and their salts. The compounds of the formula (1) according to the invention (and/or their salts), 5 hereinbelow together referred to as "compounds according to the invention", have an outstanding herbicidal activity against a broad spectrum of economically important monocotyledonous and dicotyledonous annual harmful plants. The active substances also act efficiently on perennial harmful plants which produce shoots from rhizomes, rootstocks or other perennial organs and which are difficult to control. 0 The present invention therefore also relates to a method of controlling unwanted plants or for regulating the growth of plants, preferably in crops of plants, where one or more compound(s) according to the invention is/are applied to the plants (for example harmful plants such as monocotyledonous or dicotyledonous weeds or 5 undesired crop plants), to the seeds (for example grains, seeds or vegetative propagules such as tubers or shoot parts with buds) or to the area on which the plants grow (for example the area under cultivation). In this context, the compounds according to the invention can be applied for example pre-planting (if appropriate also by incorporation into the soil), pre-emergence or post-emergence. Examples of 0 individual representatives of the monocotyledonous and dicotyledonous weed flora which can be controlled by the compounds according to the invention shall be mentioned, without the mention being intended as a limitation to certain species. Monocotyledonous harmful plants of the genera: Aegilops, Agropyron, Agrostis, 5 Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, lschaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum. ) Dicotyledonous weeds of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, WO 2010/069525 PCT/EP2009/008908 56 Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, 5 Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the compounds according to the invention are applied to the soil surface before 0 germination, either the emergence of the weed seedlings is prevented completely or the weeds grow until they have reached the cotyledon stage, but then stop their growth and, finally, die completely after three to four weeks have elapsed. When the active substances are applied post-emergence to the green plant parts, 5 growth stops after the treatment, and the harmful plants remain in the growth stage of the time of application or die fully after a certain period of time, so that competition by weeds, which is harmful to the crop plants, is thus eliminated at an early point in time and in a sustained manner. O Although the compounds according to the invention display an outstanding herbicidal activity against monocotyledonous and dicotyledonous weeds, crop plants of economically important crops, for example dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, lpomoea, Lactuca, Linum, Lycopersicon, Nicotiana, Phaseolus, Pisum, 5 Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Triticale, Triticum, Zea, in particular Zea and Triticum, are damaged only to an insignificant extent, or not at all, depending on the structure of the respective compound according to the invention and its application rate. This is why the present 0 compounds are highly suitable for the selective control of undesired plant growth in plant crops such as agriculturally useful plants or ornamentals. WO 2010/069525 PCT/EP2009/008908 57 Moreover, the compounds according to the invention (depending on their respective structure and the application rate applied) have outstanding growth-regulatory properties in crop plants. They engage in the plant metabolism in a regulatory fashion and can therefore be employed for the influencing, in a targeted manner, of 5 plant constituents and for facilitating harvesting, such as, for example, by triggering desiccation and stunted growth. Moreover, they are also suitable for generally controlling and inhibiting undesired vegetative growth without destroying the plants in the process. Inhibiting the vegetative growth plays an important role in many monocotyledonous and dicotyledonous crops since for example lodging can be 0 reduced, or prevented completely, hereby. Owing to their herbicidal and plant-growth-regulatory properties, the active substances can also be employed for controlling harmful plants in crops of genetically modified plants or plants which have been modified by conventional 5 mutagenesis. As a rule, the transgenic plants are distinguished by especially advantageous properties, for example by resistances to certain pesticides, mainly certain herbicides, resistances to plant diseases or causative organisms of plant diseases, such as certain insects or microorganisms such as fungi, bacteria or viruses. Other special properties relate for example to the harvested material with 0 regard to quantity, quality, storability, composition and specific constituents. Thus, transgenic plants with an increased starch content or a modified starch quality or those with a different fatty acid composition of the harvested material are known. It is preferred to use the compounds according to the invention or their salts in 5 economically important transgenic crops of useful plants and ornamentals, for example of cereals such as wheat, barley, rye, oats, sorghum and millet, rice, cassava and corn or else crops of sugar beet, cotton, soybean, oil seed rape, potato, tomato, peas and other vegetables. It is preferred to employ the compounds according to the invention as herbicides in crops of useful plants which are resistant, D or have been made resistant by recombinant means, to the phytotoxic effects of the herbicides. WO 2010/069525 PCTIEP20091008908 58 Conventional ways of generating novel plants which, in comparison with existing plants, have modified properties are, for example, traditional breeding methods and the generation of mutants. Alternatively, novel plants with modified properties can be generated with the aid of recombinant methods (see, for example, EP-A-0221044, 5 EP-A-01 31624). For example, the following have been described in several cases: - recombinant modifications of crop plants for the purposes of modifying the starch synthesized in the plants (for example WO 92/11376, WO 92/14827, WO 91/19806), - transgenic crop plants which are resistant to certain herbicides of the 0 glufosinate type (cf., for example, EP-A-0242236, EP-A-242246) or of the glyphosate type (WO 92/00377) or of the sulfonylurea type (EP-A-0257993, US-A-5013659), - transgenic crop plants, for example cotton, which is capable of producing Bacillus thuringiensis toxins (Bt toxins), which make the plants resistant to 5 certain pests (EP-A-0142924, EP-A-0193259), - transgenic crop plants with a modified fatty acid composition (WO 91/13972), - genetically modified crop plants with novel constituents or secondary metabolites, for example novel phytoalexins, which bring about an increased disease resistance (EPA 309862, EPA0464461), 0 - genetically modified plants with reduced photorespiration which feature higher yields and higher stress tolerance (EPA 0305398), - transgenic crop plants which produce pharmaceutically or diagnostically important proteins ("molecular pharming"), - transgenic crop plants which are distinguished by higher yields or better 5 quality, - transgenic crop plants which are distinguished by a combination, for example of the abovementioned iovel properties ("gene stacking"). A large number of molecular-biological techniques by means of which novel 0 transgenic plants with modified properties can be generated are known in principle; see, for example, I. Potrykus and G. Spangenberg (eds.) Gene Transfer to Plants, Springer Lab Manual (1995), Springer Verlag Berlin, Heidelberg. or Christou, WO 2010/069525 PCT/EP2009/008908 59 "Trends in Plant Science" 1 (1996) 423-431). To carry out such recombinant manipulations, it is possible to introduce nucleic acid molecules into plasmids, which permit a mutagenesis or sequence modification by 5 recombination of DNA sequences. For example, base substitutions can be carried out, part-sequences can be removed, or natural or synthetic sequences may be added with the aid of standard methods. To link the DNA fragments with one another, it is possible to add adapters or linkers to the fragments; see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd ed., Cold 0 Spring Harbor Laboratory Press, Cold Spring Harbor, NY; or Winnacker "Gene and Klone", VCH Weinheim 2nd ed., 1996 The generation of plant cells with a reduced activity for a gene product can be achieved for example by the expression of at least one corresponding antisense 5 RNA, a sense RNA for achieving a cosuppression effect or by the expression of at least one correspondingly constructed ribozyme, which specifically cleaves transcripts of the abovementioned gene product. To this end, it is possible firstly to use DNA molecules which comprise all of the coding sequence of a gene product, including any flanking sequences which may be 0 present, or else DNA molecules which only comprise parts of the coding sequence, it being necessary for these parts to be long enough to bring about an antisense effect in the cells. It is also possible to use DNA sequences which have a high degree of homology with the coding sequences of a gene product, but which are not entirely identical. 5 When expressing nucleic acid molecules in plants, the protein synthesized may be localized in any compartment of the plant cell. In order to achieve localization in a particular compartment, however, it is possible for example to link the coding region to DNA sequences which ensure the localization in a specific compartment. Such 0 sequences are known to the skilled worker (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al., Plant J. 1 (1991), 95-106). The nucleic acid molecules can also be WO 2010/069525 PCT/EP2009/008908 60 expressed in the organelles of the plant cells. The transgenic plant cells can be regenerated by known techniques to give intact plants. In principle, the transgenic plants may be plants of any plant species, that is 5 to say both monocotyledonous and dicotyledonous plants. Thus, transgenic plants can be obtained which feature modified properties as the result of overexpression, suppression or inhibition of homologous (= natural) genes or gene sequences or expression of heterologous (= foreign) genes or gene 0 sequences. It is preferred to employ the compounds according to the invention in transgenic crops which are resistant to growth regulators such as, for example, dicamba, or against herbicides which inhibit essential plant enzymes, for example acetolactate 5 synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), or against herbicides from the group of the sulfonylureas, glyphosate, glufosinate or benzoylisoxazoles and analogous active substances. o When the active substances according to the invention are used in transgenic crops, effects are frequently observed - in addition to the effects on harmful plants which can be observed in other crops - which are specific for the application in the transgenic crop in question, for example a modified or specifically widened spectrum of weeds which can be controlled, modified application rates which may be 5 employed for application, preferably good combinability with the herbicides to which the transgenic crop is resistant, and an effect on growth and yield of the transgenic crop plants. The invention therefore also relates to the use of the compounds according to the 0 invention as herbicides for controlling harmful plants in transgenic crop plants. The compounds according to the invention can be used in the form of wettable WO 2010/069525 PCT/EP2009/008908 61 powders, emulsifiable concentrates, sprayable solutions, dusting products or granules in the customary formulations. The invention therefore also provides herbicidal and plant growth-regulating compositions which comprise the compounds according to the invention. 5 The compounds according to the invention can be formulated in various ways according to which biological and/or physicochemical parameters are required. Possible formulations include, for example: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), 0 emulsions (EW) such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), oil- or water-based dispersions, oil-miscible solutions, capsule suspensions (CS), dusting products (DP), seed-dressing products, granules for scattering and soil application, granules (GR) in the form of microgranules, spray granules, coated granules and adsorption granules, water-dispersible granules 5 (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes. These individual formulation types are known in principle and are described, for example, in: Winnacker-K~chler, "Chemische Technologie" [Chemical technology], Volume 7, C. Hanser Verlag Munich, 4th Ed. 1986, Wade van Valkenburg, "Pesticide Formulations", Marcel Dekker, N.Y., 1973; K. Martens, "Spray Drying" Handbook, 0 3rd Ed. 1979, G. Goodwin Ltd. London. The necessary formulation assistants, such as inert materials, surfactants, solvents and further additives, are likewise known and are described, for example, in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers", 2nd Ed., Darland 5 Books, Caldwell N.J., H.v. Olphen, "Introduction to Clay Colloid Chemistry"; 2nd Ed., J. Wiley & Sons, N.Y.; C. Marsden, "Solvents Guide"; 2nd Ed., Interscience, N.Y. 1963; McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood N.J.; Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., N.Y. 1964; Sch6nfeldt, "Grenzflschenaktive Athylenoxidaddukte" 0 [Interface-active ethylene oxide adducts], Wiss. Verlagsgesell., Stuttgart 1976; Winnacker-KOchler, "Chemische Technologie", Volume 7, C. Hanser Verlag Munich, 4th Ed. 1986. WO 20101069525 PCT/EP2009/008908 62 Wettable powders are preparations which can be dispersed uniformly in water and, as well as the active compound, apart from a diluent or inert substance, also comprise surfactants of the ionic and/or nonionic type (wetting agents, dispersants), 5 for example polyoxyethylated alkylphenols, polyoxyethylated fatty alcohols, polyoxyethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium lignosulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate or else sodium oleylmethyltauride. To prepare the wettable powders, the active herbicidal 0 ingredients are ground finely, for example in customary apparatus such as hammer mills, blower mills and air-jet mills and simultaneously or subsequently mixed with the formulation assistants. Emulsifiable concentrates are prepared by dissolving the active compound in an 5 organic solvent, for example butanol, cyclohexanone, dimethylformamide, xylene or else relatively high-boiling aromatics or hydrocarbons or mixtures of the organic solvents with addition of one or more surfactants of the ionic and/or nonionic type (emulsifiers). The emulsifiers used may, for example, be: calcium alkylarylsulfonates such as calcium dodecylbenzenesulfonate, or nonionic emulsifiers such as fatty acid 0 polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters, for example sorbitan fatty acid esters, or polyoxyethylene sorbitan esters, for example polyoxyethylene sorbitan fatty acid esters. 5 Dusting products are obtained by grinding the active compound with finely divided solid substances, for example talc, natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth. Suspension concentrates may be water- or oil-based. They may be prepared, for 0 example, by wet grinding by means of commercial bead mills and optional addition of surfactants as have, for example, already been listed above for the other formulation types. WO 2010/069525 PCT/EP2009/008908 63 Emulsions, for example oil-in-water emulsions (EW), can be prepared, for example, by means of stirrers, colloid mills and/or static mixers using aqueous organic solvents and optionally surfactants, as have, for example, already been listed above for the other formulation types. 5 Granules can be produced either by spraying the active compound onto adsorptive granulated inert material or by applying active compound concentrates by means of adhesives, for example polyvinyl alcohol, sodium polyacrylate or else mineral oils, onto the surface of carriers such as sand, kaolinites or of granulated inert material. It 0 is also possible to granulate suitable active compounds in the manner customary for the production of fertilizer granules - if desired in a mixture with fertilizers. Water-dispersible granules are prepared generally by the customary processes such as spray-drying, fluidized bed granulation, pan granulation, mixing with high 5 speed mixers and extrusion without solid inert material. For the preparation of pan, fluidized bed, extruder and spray granules, see, for example, processes in "Spray-Drying Handbook" 3rd ed. 1979, G. Goodwin Ltd., London; J.E. Browning, "Agglomeration", Chemical and Engineering 1967, pages 147 ff; "Perry's Chemical Engineer's Handbook", 5th Ed., McGraw-Hill, New York 0 1973, p. 8-57. For further details regarding the formulation of crop protection compositions, see, for example, G.C. Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pages 81-96 and J.D. Freyer, S.A. Evans, "Weed Control 5 Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103. The agrochemical formulations contain generally from 0.1 to 99% by weight, in particular from 0.1 to 95% by weight, of active compound of the formula (1). In wettable powders, the active compound concentration is, for example, from about 0 10 to 90% by weight; the remainder to 100% by weight consists of customary formulation constituents. In the case of emulsifiable concentrates, the active compound concentration may be from about 1 to 90% by weight, preferably from 5 to WO 2010/069525 PCT/EP2009/008908 64 80% by weight. Dust-type formulations contain from 1 to 30% by weight of active compound, preferably usually from 5 to 20% by weight of active compound; sprayable solutions contain from about 0.05 to 80% by weight, preferably from 2 to 50% by weight of active compound. In water-dispersible granules, the active 5 compound content depends partly on whether the active compound is present in solid or liquid form and which granulation assistants, fillers, etc. are used. In the granules dispersible in water, the content of active compound is, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight. 0 In addition, the active compound formulations mentioned optionally comprise the respective customary adhesives, wetting agents, dispersants, emulsifiers, penetrants, preservatives, antifreeze agents and solvents, fillers, carriers and dyes, defoamers, evaporation inhibitors and agents which influence the pH and the viscosity. 5 Based on these formulations, it is also possible to prepare combinations with other pesticidally active compounds, such as, for example, insecticides, acaricides, herbicides, fungicides, and also with safeners, fertilizers and/or growth regulators, for example in the form of a finished formulation or as a tank mix. Suitable safeners are, 0 for example, mefenpyr-diethyl, cyprosulfamide, isoxadifen-ethyl, cloquintocet-mexyl and dichlormid. Active compounds which can be employed in combination with the compounds according to the invention in mixed formulations or in the tank mix are, for example, 5 known active compounds which are based on the inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase, as are described in, for example, Weed 0 Research 26 (1986) 441-445 or "The Pesticide Manual", 14th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2003 and the literature cited therein. Known herbicides or plant growth regulators which can be combined WO 2010/069525 PCTIEP20091008908 65 with the compounds according to the invention are, for example, the following active substances (the compounds are either designated by the common name according to the International Organization for Standardization (ISO) or by a chemical name, if appropriate together with the code number) and always comprise all use forms such 5 as acids, salts, esters and isomers such as stereoisomers and optical isomers. In this context, one and in some cases also several use forms are mentioned by way of example: acetochlor, acibenzolar, acibenzolar-S-methyl, acifluorfen, acifluorfen-sodium, 0 aclonifen, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryne, amicarbazone, amidochlor, amidosulfuron, aminocyclopyrachlor, aminopyralid, amitrole, ammonium sulfamate, ancymidol, anilofos, asulam, atrazine, azafenidin, azimsulfuron, aziprotryne, BAH-043, BAS-140H, BAS-693H, BAS-714H, BAS-762H, BAS-776H, BAS-800H, beflubutamid, benazolin, benazolin-ethyl, bencarbazone, 5 benfluralin, benfuresate, bensulide, bensulfuron-methyl, bentazone, benzfendizone, benzobicyclon, benzofenap, benzofluor, benzoylprop, bifenox, bilanafos, bilanafos sodium, bispyribac, bispyribac-sodium, bromacil, bromobutide, bromofenoxim, bromoxynil, bromuron, buminafos, busoxinone, butachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butylate, cafenstrole, carbetamide, carfentrazone, 0 carfentrazone-ethyl, chlomethoxyfen, chloramben, chlorazifop, chlorazifop-butyl, chlorbromuron, chlorbufam, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlormequat-chloride, chlornitrofen, chlorophthalim, chlorthal-dimethyl, chlorotoluron, chlorsulfuron, cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clethodim, clodinafop, 5 clodinafop-propargyl, clofencet, clomazone, clomeprop, cloprop, clopyralid, cloransulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cyclanilide, cycloate, cyclosulfamuron, cycloxydim, cycluron, cyhalofop, cyhalofop-butyl, cyperquat, cyprazine, cyprazole, 2,4-D, 2,4-DB, daimuron/dymron, dalapon, daminozide, dazomet, n-decanol, desmedipham, desmetryn, detosyl-pyrazolate ) (DTP), diallate, dicamba, dichlobenil, dichlorprop, dichlorprop-P, diclofop, diclofop methyl, diclofop-P-methyl, diclosulam, diethatyl, diethatyl-ethyl, difenoxuron, difenzoquat, diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dikegulac- WO 2010/069525 PCT/EP2009/008908 66 sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimethipin, dimetrasulfuron, dinitramine, dinoseb, dinoterb, diphenamid, dipropetryn, diquat, diquat-dibromide, dithiopyr, diuron, DNOC, eglinazine-ethyl, endothal, EPTC, esprocarb, ethalfluralin, ethametsulfuron-methyl, 5 ethephon, ethidimuron, ethiozin, ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etobenzanid, F-5331, i.e. N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl) 4,5-dihydro-5-oxo-1 H-tetrazol-1 -yl]phenyl]ethanesulfonamide, fenoprop, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fentrazamide, fenuron, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, 0 fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, fluazolate, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet (thiafluamide), flufenpyr, flufenpyr-ethyl, flumetralin, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, flumipropyn, fluometuron, fluorodifen, fluoroglycofen, fluoroglycofen-ethyl, flupoxam, flupropacil, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, flurenol, 5 flurenol-butyl, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurprimidol, flurtamone, fluthiacet, fluthiacet-methyl, fluthiamide, fomesafen, foramsulfuron, forchlorfenuron, fosamine, furyloxyfen, gibberellic acid, glufosinate, L-glufosinate, L glufosinate-ammonium, glufosinate-ammonium, glyphosate, glyphosate isopropylammonium, H-9201, halosafen, halosulfuron, halosulfuron-methyl, 0 haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop methyl, haloxyfop-P-methyl, hexazinone, HNPC-9908, HOK-201, HW-02, imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin, imazethapyr, imazosulfuron, inabenfide, indanofan, indoleacetic acid (IAA), 4-indol-3-ylbutyric acid (IBA), iodosulfuron, iodosulfuron-methyl-sodium, 5 ioxynil, isocarbamid, isopropalin, isoproturon, isouron, isoxaben, isoxachlortole, isoxaflutole, isoxapyrifop, KUH-043, KUH-071, karbutilate, ketospiradox, lactofen, lenacil, linuron, maleic hydrazide, MCPA, MCPB, MCPB-methyl, -ethyl and -sodium, mecoprop, mecoprop-sodium, mecoprop-butotyl, mecoprop-P-butotyl, mecoprop-P dimethylammonium, mecoprop-P-2-ethylhexyl, mecoprop-P-potassium, mefenacet, 0 mefluidide, mepiquat-chloride, mesosulfuron, mesosulfuron-methyl, mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, methazole, methoxyphenone, methyldymron, 1-methylcyclopropene, methyl isothiocyanate, WO 2010/069525 PCT/EP20091008908 67 metobenzuron, metobenzuron, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monalide, monocarbamide, monocarbamide dihydrogen sulfate, monolinuron, monosulfuron, monuron, MT 128, MT-5950, i.e. N-[3-chloro-4-(1-methylethyl)phenyl] 5 2-methylpentanamide, NGGC-01 1, naproanilide, napropamide, naptalam, NC-31 0, i.e. 4-(2,4-dichlorobenzoyl)-1-methyl-5-benzyloxypyrazole, NC-620, neburon, nicosulfuron, nipyraclofen, nitralin, nitrofen, nitrophenolat-sodium (isomer mixture), nitrofluorfen, nonanoic acid, norflurazon, orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefone, oxyfluorfen, paclobutrazole, 0 paraquat, paraquat dichloride, pelargonic acid (nonanoic acid), pendimethalin, pendralin, penoxsulam, pentanochlor, pentoxazone, perfluidone, pethoxamid, phenisopham, phenmedipham, phenmedipham-ethyl, picloram, picolinafen, pinoxaden, piperophos, pirifenop, pirifenop-butyl, pretilachlor, primisulfuron, primisulfuron-methyl, probenazole, profluazol, procyazine, prodiamine, prifluraline, 5 profoxydim, prohexadione, prohexadione-calcium, prohydrojasmone, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyzamide, prosulfalin, prosulfocarb, prosulfuron, prynachlor, pyraclonil, pyraflufen, pyraflufe n-ethyl, pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron-ethyl, pyrazoxyfen, 0 pyribambenz, pyribambenz-isopropyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil, secbumeton, sethoxydim, siduron, simazine, simetryn, SN 5 106279, sulcotrione, sulf-allate (CDEC), sulfentrazone, sulfometuron, sulfometuron methyl, sulfosate (glyphosate-trimesium), sulfosulfuron, SYN-523, SYP-249, SYP 298, SYP-300, tebutam, tebuthidron, tecnazene, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbuchlor, terbumeton, terbuthylazine, terbutryne, TH-547, i.e. propyrisulfuron, thenylchlor, thiafluamide, thiazafluron, thiazopyr, 0 thidiazimin, thidiazuron, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, tiocarbazil, topramezone, tralkoxydim, triallate, triasulfuron, triaziflam, triazofenamide, tribenuron, tribenuron-methyl, trichloroacetic WO 2010/069525 PCT/EP2009/008908 68 acid (TCA), triclopyr, tridiphane, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifluralin, triflusulfuron, triflusulfuron-methyl, trimeturon, trinexapac, trinexapac-ethyl, tritosulfuron, tsitodef, uniconazole, uniconazole-P, vernolate, ZJ-0166, ZJ-0270, ZJ 0543, ZJ-0862 and also the following compounds: o o 0 0 0 0. I I N CHS N OH 3 O CFa O CF3 OF3 3 0 H O3F 0 H 3 OHC OH 3 CC H N C I C N Os HO N/ O H3 0 / HO 0 5N EtO 2 0H 2 O o H 3 0H 3 C OH 3 Ci NH 2 N N 0 ' N *,F 0 0H1/ 0N H3OH 3 CI NH 2 F 0 N 5 For use, the formulations in commercial form are, if appropriate, diluted in a customary manner, for example in the case of wettable powders, dispersions and water-dispersable granules with water. Preparations in the form of dusts, granules for soil application or granules for broadcasting and sprayable solutions are usually ) not diluted with other inert substances prior to application. WO 20101069525 PCT/EP2009/008908 69 The application rate of the compounds of the formula (1) varies according to the external conditions such as, inter alia, temperature, humidity and the type of herbicide used. It may vary within wide limits, for example between 0.001 and 1.0 kg/ha or more of active substance; however, preferably is it between 0.005 and 750 5 g/ha. In addition to the herbicidal action, the compounds according to the invention also have good insecticidal action. Accordingly, the invention also relates to their use as insecticides. 0 WO 20101069525 PCT/EP2009/008908 70 The examples below serve to illustrate the invention. Chemical examples 1. Preparation of 2-cyclobutyl-4-(2,4-d ich I orop henyl)-5-hyd roxy-6-methyl-2 H 5 pyridazin-3-one (No. 1 of Table 91) At <0, a solution of 10 ml of DMF and 0.53 g (2.0 mmol) of ethyl 2-cyclobutyl-{[2-(2, 4-dichlorophenyl)acetyl]hydrazono}propionate were added dropwise to 0.331 g (2 eq) of potassium t-butoxide in 10 ml of DMF over a period of 2 hours. The mixture 0 was allowed to stirr at 0" for 90 min, and the reaction solution was then poured into 100 ml of cooled 0.5 N hydrochloric acid. The solution was concentrated under reduced pressure and taken up in water, concentrated once more and taken up in 50 ml of water. The mixture was extracted twice with in each case 50 ml of ethyl acetate, and the combined organic phases were dried with sodium sulfate, 5 concentrated under reduced pressure and purified by column chromatography (silica gel, n-heptane/EtOAc gradient). This gave 0.1 g of pure product. The following compounds were prepared analogously to Example 1 above: 0 Table 91: Compounds of the general formula (1) according to the invention in which G is hydrogen. A OH Ny B O X No- X Y Z. 'A B Analytical dat a 1-1-a-1 CI 4-CI H Me c-butyl 'H--NMR, 400MHz, d6-DM,07.68 (d, 1 H); 7.45 (dd, 1 H), 7.29 (d, 1 H); 5.29 (qunitett, 1 H); 2.40 (m , 2H), 2,28 (s, 3H), 2.19 (m ,2H), 1.75 (m, 2H) 1-1-a-2 CI 4-CI 6-Et c-pentyl Me 'H-NMR, 400MHz, d6-DMSO, 7.51 (d, 1 H); 7.37 (d, 1 H); 3,57 (s, 3H); 3.28 (m, 1 H), 2.30 (m, 2H), 1.92 (m, 2H), 1.55 1.80 (m ,6H), 1.00 (t, 3H) |I-1-a-3 I CI I4-Cl 6-E Me benzyl I WO 20101069525 PCT/EP2009/008908 71 No. X Y Z A B Analytica data. l-1-a-4 CI 4-Me 6-Me Me c-Pr-CH 2 'H-NMR, 400MHz, d6-DMSO, 7.08 (d, 1H); 6.93 (d, 1H); 3.72 (d, 2H); 2.25 (s, 3H), 2.15 (s, 3H), 2.02 (d, 3H), 1.00 (m ,1H), 0.40 (m, 2H), 0.22 (m, 2H) I-1-a-5 Cl 6-CI H c-pentyl Me 'H-NMR, 400MHz, d6-DMSO, 10.7 (bs, 1H), 7.52 (d, 2H); 7.44 (d, 1H); 3.56 (s, 3H); 3.30 (m, 1H), 2.30 (m, 2H), 1.94 (m, 2H), 1.55 - 1.80 (m ,6H) 1-1-a-6 CI 4-Cl 6-Et Me c-Pr-CH 2 'H-NMR, 400MHz, d6-DMSO, 10.5 (bs, 1 H), 7.51 (d, 1 H); 7.35 (d, 1 H); 3.88 (d, 2H); 2.33 (m, 2H), 2.25 (s, 3H), 1.22 (m, 1 H), 1.03 (t ,3H), 0.45 (m, 2H), 0.32 (m, 2H) 1-1-a-7 CI 6-Cl H Me 2- 'H-NMR, 400MHz, d6-OMSO, 10.8 (bs, phenylethyl 1H), 7.52 (d, 2H); 7.42 (t, 1H); 7.28-7.12 (m, 5H), 4.22 (t, 2H); 2.98 (t, 2H), 2.22 (s, 3H), 1-1-a-8 CI 6-C H Me 2-(2'-chloro- 1 H-NMR, 400MHz, d6-DMSO, 10.8 (bs, phenyl)ethyl 1H), 7.52 (d, 2H); 7.42 (m, 3H); 7.20 (m, 2H), 4.25 (t, 2H); 3.11 (t, 2H), 2.15 (s, 3H), I-l-a-9 I H H Me 2- 1 H-NMR, 400MHz, d6-DMSO, 10.4 (bs, phenylethyl 1H), 7.91 (d, 1H), 7.43 (t, 1H); 7.27 (m, 2H); 7.23 - 7.10-(m, 5H), 4.18 (m, 2H); 2.98 (t, 2H), 2.21 (s, 3H), 1-1-a-10 I H H Me 2-(2'-chloro- 'H-NMR, 400MHz, d6-DMSO, 10.4 (bs, phenyl)ethyl 1H), 7.90 (d. 1H), 7.41 (m, 2H); 7.27 (m, 3H); 7.12 (m, 2H), 4.22 (m, 2H); 3.11 (m, 2H), 2.16 (S. 3H), 1-1-a-11 CI 4-Cl 6-Et c-hexyl-CH 2 Me 'H-NMR, 400MHz, d6-DMSO, 7.53 (d, 1 H); 7.37 (d, 1 H); 3.58 (s, 3H); 2.50 (m, 2H, obscured by solvent), 2.30 (m, 2H), 1.70 (m, 6H), 1.30 - 0.90 (cluster of signals, 9H) 1-1-a-12 CI 4-CI H c-pentyl-CH 2 Me 'H-NMR, 400MHz, d6-DMSO, 10.4 (bs, 1H), 7.70 (s, 1H), 7.41 (dd, 1H); 7.31 (d, 1H); 3.58 (s, 3H), 2.63 (d, 2H); 2.24 (m, 1 H), 1.8 - 1.2 (cluster of signals, 8H), 1-1-a-13 CI 6-CI 4-CI Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.65 (s, 2H); 7.22-7.34 (m, 5H); 5,18 (s, 2H); 2,21 (s, 3H) I-1-a-14 Cl 6-F 3-Me Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.23-7.34 (m, 7H); 5,18 (s, 2H); 2,24 (s. 6H) I-I-a-I5 F 6-F 3-F Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.49 (ddd, 1H); 7.24-7.34 (m, 5H); 7.10-7.16 (m, 1H); 5,18 (s, 2H); 2,25 (s. 3H) I-1-a-16 EtO 6-F 3-F Me Bz 'H-NMR, 600MHz, d6-DMSO, 7.24-7.38 (m, 6H), 7.02 (ddd, 1H), 5.28 (d, 1H), 5.11 (d, 1H), 4.02 (qd, 1H), 3.94 (qd, 1H), 2,24 (s, 3H), 1.03 (t, 3H) WO 2010/069525 PCT/EP2009/008908 72 No. X Y Z A B Analytical data 1-1-a-17 F 6-F 3-EtO Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.15-7.34 (m, 6H), 6.97-7.02 (m, 1H), 5.17 (s, 2H), 4.11 (q, 2H), 2,24 (s, 3H), 1.34 (t, 3H) 1-1-a-18 F H 5-CI Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.41-7.45 (m, 1H), 7.24-7.37 (m, 7H), 5.16 (s, 2H), 2.23 (s, 3H) -1-a-19 C1 6-Cl H c-hexyl-CH 2 Me IH-NMR, 400MHz, d6-DMSO, 7.52 (d. 2H); 7.42 (dd, 1 H); 3.58 (s, 3H); 2.50 (m, 2H, obscured by solvent), 2.30 (m, 2H), 1.70 (m, 6H), 1.20 (m, 3H), 0.97 (m, 3H) 1-1 -a-20 CI 6-Cl H Me 2-(4'-chloro- 'H-NMR, 400MHz, d6-DMSO, 10.8 (bs, phenyl)ethyl 1H), 7.52 (d, 2H), 7.44 (dd, 1H); 7.30 (m, 2H), 7.18 (d, 2H); 4.22 (t, 2H); 2.98 (t, 2H), 2.21 (s, 3H), 1-1-a-21 CI 4-CI H Me 2-(4'-chloro- 'H-NMR, 400MHz, d6-DMSO, 10.6 (bs, phenyl)ethyl 1H), 7.70 (s, 1H), 7.47 (dd, 1H); 7.32 (m, 2H), 7.26 (d, 1H), 7.18 (d, 2H); 4.16 (m, 2H); 2.98 (t, 2H), 2.21 (s, 3H), 1-1-a-22 Cl 4-CI H Me 2-(2'-chloro- 'H-NMR, 400MHz, d6-DMSO, 10.6 (bs, phenyl)ethyl 1H), 7.70 (s, 1H), 7.47 (dd, 1H); 7.40 (m, 1H), 7.22 (m, 4H); 4.22 (m, 2H); 3.11 (t, 2H), 2.17 (s, 3H), 1-1-a-23 F 6-F H Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.43-7.51 (m, 1H); 7.23-7.33 (m, 6H); 7.06-7.12 (m, 1H); 5.18 (s, 2H); 2.25 (s, 3H) I-1-a-24 CI 6-F 4-F Me Bz oil I-1-a-25 CI 6-F H Me Bz 'H-NMR, 400MHz, d6-DMSO, 7.15-7.48 (m, 8H) ; 5.24 (d, 1H) : 5.18 (d, 1H); 2.25 (s, 3H) 1-1 -a-26 CI 6-CF 3 H Me 2- 'H-NMR, 400MHz, CDCl 3 , 7.68 (d, 2H), phenylethyl 7.47 (t, 1H); 7.21 (m, 5H); 6.20 (bs, IH),4,28 (m, 2H); 3.06 (t, 2H), 2.28 (s, 3H), I-1-a-27 I H H Me 2-(4'-chloro- 1 H-NMR, 400MHz, CDC1 3 , 7.99 (d, 2H), phenyl)ethyl 7.47 (t, 1H); 7-20 (m, 6H); 5.60 (bs, 1H),4.32 (m, 2H); 3.08 (t, 2H), 2.32 (s, 3H), 1-1 -a-28 CI 4-CI 6-Et c-pentyl-CH 2 1 Me 'H-NMR, 400MHz, d6-DMSO, 10.4 (bs, 1H), 7.52 (d, 1K), 7.37 (d, 1H); 3.58 (s, 3H), 2.58 (d, 2H); 2.31 (m, 2H), 2.22 (m, 1 H), 1.8 - 1.2 (cluster of signals, 8H), 1.03 (t, 3H) 1-1-a-29 CI 6-CI H c-pentyl-CH 2 Me 'H-NMR, 400MHz, d6-DMSO, 10.7 (bs, 1H). 7.52 (d, 2H), 7.41 (dd, 1H); 3.58 (s, 3H), 2.63 (d, 2H); 2.23 (m, 1H), 1.8 - 1.2 (cluster of signals, 8H), 1-1-a-30 CI 6-Cl H c-Pr Me 1 H-NMR, 400MHz, CDCl, 7.45 (d, 2H), 7.33 (t, 1H); 5.80 (bs, 1H),3.72 (s, 3H); 2.05 (m, 1H), 0.95 (m, 4H), l-1-a-31 H 3-CF 3 H c-Pr-CH 2 Me WO 2010/069525 PCT/EP2009/008908 73 No. X Y Z A B Analytical data 1-1-a-32 CI 6-Cl H c-Pr-CH 2 Me I-1-a-33 CI 4-C H c-Pr-CH 2 Me I-1-a-34 H 3-CF 3 H c-Pr-CH 2 i-Pr I-1-a-35 H 2-CI H c-Pr-CH 2 i-Pr I-1-a-36 CI 6-Cl H c-Pr-CH 2 i-Pr I-1-a-37 H 2-CI H 2-phenylethyl Me 3. Preparation of 5-acetoxy-6-cyclopentyl-4-(2,6-dichlorophenyl)-2-methyl-3(2H) pyridazinone (No. 1 of Table 92) 5 0.25 g (0.74 mmol) of the compounds 1-1-a-5 according to the invention of Table 91 and 0.12 g of diisopropylethylamine (1.3 eq) and a spatula tip of DMAP were initially charged in 15 ml of ethyl acetate and heated to the boil under reflux. 0.058 g (1.0 eq) of acetyl chloride was then dissolved in 2 ml of ethyl acetate and added dropwise over a period of 10 min. The mixture was allowed to stir for five hours, another 0.04 g 0 of diisopropylamine and 0.02 g of acetyl chloride were added, and after a further 2 hours of reaction time the mixture was cooled and 20 ml of water and 50 ml of ethyl acetate were added. The organic phase was separated off and dried giving, after chromatographic purification (silica gel, gradient ethyl acetate/n-heptane), 0.04 g of pure product. 5 The compounds of Table 92 can be obtained analogously to the method mentioned above. Table 92: Compounds of the general formula (1) according to the invention in which G is C(=0)R. A O-C(=O)R N 0 B O X WO 2010/069525 PCT/EP2009/008908 74 NO X Y Z RI A B Analytical data 1-1-b-I Cl 6-Cl H Me c-pentyl Me 'H-NMR, 400MHz, cDC1 3 , 7.39 (d, 2H); 7.30 (d, 1H); 3.82 (s, 3H); 3.03 (m, IH), 2.02 (s, 3H), 1.60 - 1.94 (cluster of signals, 8H) 1-1-b-2 Cl 4-C 6-Et i-Pr c-pentyl Me 'H-NMR, 400MHz, CDC 3 , 7.32 (d, 1H); 7.22 (d. 1H); 3.82 (s, 3H); 2.99 (m, 1H), 2.47 (m, 2H), 1.60 - 2.05 (cluster of signals, 8H), 1.16 (t, 3H), 0.95 (dd, 6H) 4. Preparation of 4-(2,4-dichlorophenyl)-5-ethoxycarbonyloxy-2-(2-phenyl)ethyl 3(2H)-pyridazinone (No. 1 of Table 93) 1.25 g (0.61 mmol) of the compound No. I-1 -a-7 according to the invention of Table 5 91 were initially charged in 30ml of dichloromethane, and 0.438 g of triethylamine and 0.36 g of ethyl chloroformate were added. The mixture was stirred at RT overnight and then added to 30 ml of 5% strength sodium bicarbonate solution. The organic phase was separated off and then dried, concentrated and purified by column chromatography (silica gel, gradient ethyl acetate/n-heptane). Crystallisation 0 from ethyl acetate/n-heptane gave 0.28 g of pure product. The compounds of Table 93 can be obtained analogously to the method mentioned above. Table 93: Compounds of the general formula (1) according to the invention in 5 which G is C(=L)MR 2 . A O-C(=L)MR 2 NZ N --- y B 0 X No. X Y Z A B L M R2 Analytical data 1-1-c-I CI 6-CI H Me 2-phenyl- 0 0 Et iH-NMR, 400MHz, CDC13,7.39 ethyl (d, 2H); 7.18 - 7.32 (cluster of signals, 6H); 4.42 (m, 2H); 4.17 (q, 2H), 3.15 (m, 2H), 2.31 (s, 13H), 1.22 (q, 3H) WO 2010/069525 PCT/EP20091008908 75 No JX Y Z A, B L M R2 Analytical data 1-1-c-2 CI 4-Cl H Me 2-phenyl- 0 0 Et 1 H-NMR, 400MHz, CDC3, 7.52 ethyl (d, 1 H); 7.15 - 7.35 (cluster of signals, 7H); 4.40 (m, 2H); 4.15 (q, 2H), 3.13 (m, 2H), 2.31 (s, __ _ I 3H), 1.22 (q, 3H) l-1-c-3 CI 6-Cl H Me 2-(2'-C- 0 0 Et 'H-NMR, 400MHz, CDC13, 7.10 phenyl- - 7.40 (cluster of signals, 7H); ethyl 4.48 (m, 2H); 4.18 (m, 2H), 3.28 (m, 2H), 2.29 (s, 3H), 1.21 (q, 3H) -1-c4 Cl 6-Et 4-CI Me c-Pr-CH 2 0 0 Et 'H-NMR, 400MHz, d6-DMSO, 7.60 (d, 1H); 7.43 (d, 1H); 4.13 (q, 2H), 3.99 (d, 2H); 2.35 (m, 2H), 2.28 (s, 3H), 1.22 (m, 1H), 1,08 (t, 3H), 1.03 (t ,3H), 0.48 (m, 2H), 0.36 (m, 2H) 1-1-c-5 Cl 6-CI H c-pentyl Me 0 0 Et 1 H-NMR, 400MHz, CDC13), 7.39 (d, 2H); 7.29 (d, 1H); 4.11 8q, 2H), 3.83 (s, 3H); 3.12 (m, 1H), 1.96 (m, 2H), 1.82 (m, 4H), 1.65 (m ,2H), 1.13 (t, 3H) l-1-c-6 CI 6-Et 4-Cl c-pentyl Me 0 0 Et 'H-NMR, 400MHz, CDC13 7.32 (d, 1 H); 7.22 (d, 1 H); 4.08 (q, 2H), 3.83 (s, 3H); 3.08 (m, 1 H), 2.47 (m, 2H), 1.98 (m, 2H), 1.80 (m, 4H), 1.65 (m ,2H), 1.15 (m, 6H) 1-1-c-7 Cl 6-CI H Me c-Pr-CH 2 0 0 Et 'H-NMR, 400MHz, d6-DMSO, 7.62 (m, 2H); 7.52 (t, 1H); 4.36 (m, 1H), 4.13 (m, 2H), 3.99 (m, 1H); 2.28 (s, 3H), 1.30 - 1.00 (cluster of signals, 4H), 0.52 (m, 2H), 0.40 (m, 2H) l-1-c-8 I H H Me 2-phenyl- 0 0 Et 'H-NMR, 400MHz, CDC13 7.92 ethyl (d, 1H); 7.39 (t, 1 H); 7.30 - 7.05 (cluster of signals, 7H), 4.40 (m, 2H), 4.13 (q, 2H), 3.13 (t, 2H), 2.30 (s, 3H), 1.18 (m, 6H) I-1-c-9 I H H Me 2-(2'-Cl- 0 0 Et 'H-NMR, 400MHz, CDC13 7.92 phenyl- (d, 1 H); 7.35 (m, 2H); 7.27 8m, ethyl 1 H), 7.15 (m, 3H), 7.08 (m, 1H), 4.48 (m, 2H), 4.13 (q, 2H), 3.31 (m, 2H), 2.28 (s, 3H), 1.17 (m, 6H) I-1-c-10 Cl 6-Cl H CF 3 (CH 2 ) 2 Me 0 0 Et 'H-NMR, 400MHz, d6- CDCl 3 , 7.42 (m, 2H); 7.32 (t, 1H); 4.36 (m, 1H), 4.13 (m, 2H), 3.85 (s, 3H); 2.88 (t, 2H), 2.62 (m, 2H), 11.18 (t, 3H) WO 2010/069525 PCT/EP2009/008908 76 Nio. X Y Z A B L M R2 Analytical data 1-1-c-11 CI 6-Et 4-Cl c-hexyl- Me 0 0 Et 'H-NMR, 400MHz, CDClj 7.32 CH 2 (d, 1H); 7.22 (d, 1H); 4.12 (q, 2H), 3.83 (s, 3H); 2.48 (d, 2H), 2.45 (m, 2H), 1.70 (m, 6H), 1.40 - 0.90 (cluster of signals, 9H), l-1-c-12 CI 6-Cl H c-Hexyl- Me 0 0 Et 1 H-NMR, 400MHz, CDC13), CH 2 7.39 (d, 2H); 7.29 (d, 1 H); 4.11 (q, 2H), 3.83 (s, 3H); 2.48 (d, 2H), 1.70 (m, 6H), 1.20 (m, 2H), 1.15 (t, 3H), 0.99 (m, 2H), I-1-c-13 Cl 6-Cl H Me 2-(4'-C- 0 0 Et 'H-NMR, 400MHz, CDCl3), 7.40 phenyl)- (d, 2H); 7.28 (d, 1 H); 4.41 (t, ethyl 2H), 4.16 (q, 2H), 3.11 (m, 2H), 2.32 (s, 3H), 1.22 (t, 3H) 1-1-c-14 CI 4-Cl H Me 2-(4'Cl- 0 0 Et 'H-NMR, 400MHz, CDC3), phenyl)- 7.51 (s, 1H); 7.32 (d, 1H); 7.27 ethyl (d, 2H), 7.18 (m, 3H), 4.38 (m, 2H), 4.18 (q, 2H), 3.13.(m, 2H), 2.30 (s, 3H), 1.24 (t, 3H) 1-1-c-15 Cl 4-C H Me 2-(2'-Cl- 0 0 Et 'H-NMR, 400MHz, CDC13), 7.51 phenyl)- (s, 1H); 7.35 (m, 1H); 7.32 (d, ethyl 1H), 7.22 (m, 1H), 7.16 (m, 3H), 4.43 (m, 2H), 4.18 (q, 2H), 3.28.(m, 2H), 2.27 (s, 3H), 1.24 (t, 3H) 1-1-c-16 Cl 6-CF 3 H Me 2-phenyl- 0 0 Et 1 H-NMR, 400MHz, CDCI3), 7.68 ethyl (d, 2H); 7.51 (t, 1 H); 7.25 (cluster of signals, 5H), 4.42 (m, 2H), 4.18 (q, 2H), 3.13.(m, 2H), 2.29 (s, 3H), 1.24 (t, 3H) I-l-c-17 I H H Me 2-(4'-Cl- 0 0 Et 'H-NMR, 400MHz, CDC13 7.92 phenyl)- (d, 1H); 7.39 (t, IH); 7.20 (d, ethyl 2H), 7.12 (m, 2H), 4.38 (m, 2H), 4.16 (q, 2H), 3.12 (t, 2H), 2.31 (s, 3H), 1.18 (m, 3H) 1-1-c-18 CI 6-Et 4-Cl c-pentyl- Me 0 0 Et 'H-NMR, 400MHz, CDC13 7.32 CH 2 (d, 1H); 7.21 (d, 1H); 4.12 (m, 2H), 3.82 (s, 3H); 2.62 (d, 2H), 2.45 (m, 2H), 2.28 (m, 1 H), 1.70 (m, 4H), 1.40 - 1.10 (cluster of signals, 10H), 1-l-c-19 Cl 6-Cl H c-pentyl- Me 0 0 Et 'H-NMR, 400MHz, CDCl3), 7.39 CH 21 (d, 2H); 7.29 (d, 1H); 4.11 (q, 2H), 3.83 (s, 3H); 2.62 (d, 2H), 2.45 (m, 2H), 2.28 (m, 1H), 1.70 (m, 4H), 1.55 (m, 1H), 1.40 1.10 (cluster of signals, 5H), WO 2010/069525 PCTIEP2009/008908 77 No. X Y Z A LAn tical data 1-1-c-20 CI 4-CI H c-pentyl- Me 0 0 Et 'H-NMR, 400MHz, CDC3), 749 CH 2 (d, 1H); 7.32 (dd, 1H), 7.18 (d, 1H); 4.12 (q, 2H), 3.83 (s, 3H); 2.62 (d, 2H), 2.45 (m, 2H), 2.28 (m, 1 H), 1.70 (m, 4H), 1.55 (m, 1H), 1.40 - 1.10 (cluster of signals, 5H), [-1-c-21 I H H Me 2-(4'-Cl- 0 0 Me 'H-NMR, 400MHz, CDC13 7.93 phenyl)- (d, IH); 7.41 (t, IH); 7.35 -7.20 ethyl (cluster of signals, 5 H), 7.16 (d, 2H), 7.10 (m, 2H), 4.42 (m, 2H), 3.75 (s, 3H), 3.14 (t, 2H), 2.31 (s, 3H) 1-1-c-22 CI 6-Cl H c-Pr Me 0 0 Et 'H-NMR, 400MHz, CDC 3 , 7.39 (d, 2H), 7.28 (t, 1H); 4.17 (q, 2H),3.78 (s, 3H); 1.89 (m, 1H), 1.22 8t, 3H), 1.05 (m, 2H), 0.97 _______(m, 2H) 5. Preparation of 4 -( 2 -iodophenyl)-5-methylsulfonyloxy-2-(2-(2'-chlorphenyl)ethyl 3(2H)-pyridazinone (No. 1 of Table 93) 0.14 g (0.3 mmol) of the compounds No. 1-1-a-10 according to the invention of Table 5 91 were initially charged in 10 ml of dichloromethane, and 0.039 g of triethylamine and 0.034 g of methanesulfonyl chloride were added. The mixture was stirred overnight at RT and then added to 5 ml of water. The organic phase was separated off and then dried, concentrated and purified by column chromatography (silica gel, gradient ethyl acetate/n-heptane). Crystallisation from ethyl acetate/n-heptane gave 0 0.15 g of pure product. Table 94: Compounds of the general formula (1) according to the invention A O-SO R 3 N z N -~~ Ny B O X No. :X Y Z R5 A B AnalyticaI data 1-1-b- I H H Me Me 2-(4'-Cl- H-NMR, 400MHz, CDC13 7.92 (d, 1 H); pheny)-ethyl 7.46 (, 1 H); 7.33 (m, 1 H), 7.28 (m, 1 H), 7.20 (m, 1H)7.15 (m, 3H), , 4.48 (m, 2H), 3.28 (m, 2H), 2.46 (s, 3H), 2.44 (s, 3H) WO 20101069525 PCT/EP2009/008908 78 6. Examplary preparation of compounds of the formula (Ila): 3.22 g (26.4 mmol) of benzyl hydrazine together with 4.4 ml (1.2 eq) of triethylamine and 0.16 g of DMAP (0.05 eq) were initially charged in 50 ml of dichloromethane, and 5.5 g of 2,3,6-trifluorophenylacetyl chloride in 50 ml of dichloromethane were 5 then slowly added dropwise at O 0 C. The mixture was then stirred at room temperature overnight, and ammonium chloride solution was added. The organic phase was separated off, dried and concentrated. Purification by column chromatography gave 6.2 g of 2,3,6-trifluorophenylacetic acid 1 -methyihydrazide. 0 Preparation of compounds of the formula (il) Example 1: 395 mg of ethyl pyruvate were added to 1 g of 2,3,6 trifluorophenylacetic acid 1 -methylhydrazide and dissolved in 10 ml of ethanol. The reaction mixture was heated under reflux for 6 h and then concentrated under reduced pressure and purified by column chromatographiy (silica gel, mobile phase 5 cyclohexane/ethyl acetate 4:1). This gave 1.03 g of compoud 1 of Table 95. Table 95: Compounds of the general formula (11) according to the invention A N 1 CO2R z C2 / N --- y B 0 X No. X Y Z A B RW Analytical data Il-a-1 F 3-F 6-F Me Bz Et 1 H NMR (400 MHz, d6-DMSO, shift in ppm) :7.62 (s, 2H); 7.24-7.36 (m, 5H); 5.09 (s, 2H); 4.20-4.25 (m, 4H); 2.05 (bs, 3H), 1.25(t, 3H) II-a-2 Br 4-Br 6-Me Me c-Pr-CH 2 Me 1H NMR (400 MHz, d6-DMSO, shift in ppm) :768 (s, 1H); 7.46 (s, H); 3.97 (d, 2H); 3.82 (s, 3H); 3.75 (s. 2H), 2.28 (s, 3H), 2.30 and 1.92 (in each case s, together 3H), 1.05 (m, 1 H), 0.60 - 0.10 (cluster of signals, 4H) I I-a-3 CI 6-Cl 4-Cl Me BzI Et 'H NMR (400 MHz, d6-DMSO, shift in ppm) :7.62 (s, 2H); 7.24-7.36 (m, 5H); 5.09 (s, 2H); 4.20-4.25 (m, 4H); 2.05 (bs, 3H), 11.25(t, 3H) WO 20101069525 PCT/EP2009/008908 79 No. X. Y Z .. 'A B.. R. Analytical data ll-a-4 CI 3-Me 6-F Me Bz Et 'H NMR (400 MHz, d6-DMSO, shift in ppm) :7.17-7.36 (m, 7H); 5.09 (s, 2H); 4.22 (q, 2H); 4.08 (s, 2H); 2.21 (s, 3H), 2.02 (bs, 3H); 1.25(t, 3H) II-a-5 CI 6-Cl H Me c-Pr-CH 2 Me 'H NMR (400 MHz, d6-DMSO, shift in ppm) : 7,48 (d, 2H); 7.32 (t, 1 H); 4.12 (d, 2H); 3.82 (s, 3H); 3.75 (s, 2H), 2.30 and 1.88 (in each case s, together 3H), 1.05 (m, 1 H), 0.60 - 0.10 (cluster of signals, 4H) Il-a-6 CI 4-Me 6-Me Me c-Pr-CH 2 Me 'H NMR (400 MHz, d6-DMSO, shift in ppm) : 7.10 (s, IH); 6.98 (s, 1H); 3.92 (d, 2H); 3.82 (s, 3H); 3.75 (s, 2H), 2.28 (s, 3H), 2.20 (s, 3H), 2.30 and 1.92 (in each case s, together 3H), 1.05 (m, 1H), 0.60 - 0.10 (cluster of signals, 4H) Il-a-7 CI 4-Cl 6-Et c-pentyl Me Et 1 H NMR (400 MHz, CDC 3 , shift in ppm): 7.27 (s. 1H); 7.10 (s, 1H); 4.32 (m, 2H); 4.12 (s, 2H), 3.32 (s, 3H); 2.98 (s, 1H), 2.58 (m, 2H), 1.92 (m, 2H), 1.85 -1.60 (cluster of signals, 6H), 1.37 (t, 3H), 1.18 (t, 3H) ll-a-8 Cl 6-Cl H c-pentyl Me Et 'H NMR (400 MHz, CDCI 3 , shift in ppm): 7.32 (d, 2H); 7.15 (t, 1 H); 4.32 (m, 4H); 3.23 (s, 3H); 2.96 (s, 1H), 1.92 (m, 2H), 1.85 -1.60 (duster of signals, 6H), 1.37 (t, 3H) II-a-9 Cl 6-Cl H Me 2-phenyl- Me 'H NMR (400 MHz, CDCla, shift in ppm): ethyl 7.35 - 7.10 (cluster of signals, 8 H), 4.26 and 3.96 (in each case s, together 2H), 4.22 and 4.10 (in each case t, together 2H), 3.89 (s, 3H), 2.96 (m, 2H), 2.32 and 1.98 (in each case s, together 3H) II-a-10 Cl 6-Cl H Me 2-(2'-CI- Me 'H NMR (400 MHz, CDCl 3 , shift in ppm): phenyl)- 7.35 - 7.10 (cluster of signals, 7 H), 4.22 ethyl and 3.98 (in each cases, together 2H), 4.22 and 4.10 (in each case m, together 2H), 3.89 (d, 3H), 3.12 (m, 2H), 2.32 and 1.93 (in each case s, together 3H) Il-a-11 1 H H Me 2-phenyl- Me 'H NMR (400 MHz, CDC 3 , shift in ppm): ethyl 7.82 (d, 1H), 7.35 - 7.10 (cluster of signals, 7 H), 6.93 (t, 1H), 4.06 and 3.71 (in each case m, together 4H), 3.89 (s, 3H), 2.92 (m, 2H), 2.25 and 1.95 (in each case s, together 3H) II-a-12 I H H Me 2-(2'-CI- Me 1 H NMR (400 MHz, CDCla, shift in ppm): phenyl)- 7.82 (d, 1 H), 7.35 - 7.10 (cluster of signals, ethyl 6 H), 6.93 (t, 1 H), 4.08 and 3.76 (in each case m, together 4H), 3.89 (s, 3H), 3.09 (m, 2H), 2.27 and 1.98 (in each case s, together 3H) WO 20101069525 PCT/EP2009/008908 80 No. X Y Z A B R9 Analytical data I-a-13 F 6-Cl 4-F Me Bz Et 1 H NMR (400 MHz, d6-DMSO, shift in ppm) :7.22-7.36 (m, 7H); 5.07 (s, 2H); 4.22 (q, 2H); 4.04 (s, 2H); 2.02 (bs, 3H); 1.25 (t, 3H) I-a-14 F 6-F H Me Bzl Et 'H-NMR (400MHz, CD3CN, shift in ppm): 7.21-738 (m, 7H); 6.91-6.98 (m, 1 H); 5.18 (s, 2H); 4.24 (q, 2H); 3.98 (s, 2H); 2.08 (bs, 3H); 1.28 (t, 3H) Il-a-15 F 5-F H Me Bz Et 1 H NMR (400 MHz, d6-DMSO, shift in ppm) :7.16-7.44 (m, 8H), 5.06 (s, 1H), 4.23 (q, 2H), 3.99 (s, 2H), 2.00 (broad s, 3H), 1.25 (t, 3H) Il-a-16 Cl 6-Et 4-Cl Me Bz Me 'H-NMR (400MHz, d6-DMSO, shift in ppm): 7.50-7.10 (m, 6H); 7.08 (m, 1H); 5.12 (s, 2H); 4.13 (s, 2H); 3.78 8s, 3H), 2.56 (m, 2H), 2.13 and 1.85 (in each case s, together 3H) 1.14 and 1.02 (in each case m, together 3H) I-a-17 CI 6-Et 4-Cl Me c-Pr-CH 2 Me 1 H-NMR (400MHz, d6-DMSO, shift in ppm): 7.42 (s, 1H); 7.28 (s. 1H); 5.12 (s, 2H); 3.98 (d, 2H); 3.80 (s, 3H); 3.77 (s, 2H), 2.28 and 1.88 (in each case s, together 3H), 1.11 (t, 3H), 1.05 (m, 1H), 0.60 - 0.10 (cluster of signals, 4H) Il-a-18 Cl 4-Cl H Me c-butyl Me 1 H-NMR (400MHz, d6-DMSO, shift in ppm): 7.58 (s, 1H); 7.38 (s, 2H); 4,85 (s, 1H); 3.95 (s, 2H); 2,26 (m, 2H); 2.22 - 1.70 (cluster of signals, 5H), 1.65 (m, 2H) Il-a-19 Cl 6-Et 4-Cl c-hexyl- Me Et 1 H-NMR (400MHz, CDC 3 , shift in ppm): CH 2 7.28 (s, 1H), 7.11 (s, 1H), 4.32 (q, 2H), 4.11 (s, 2H), 3.32 (s, 3H), 2.58 (d, 2H), 2.42 (q, 2H), 1.72 (m, 6H), 1.38 (t, 3H), 1.20 (m, 7H), 1.02 (m, 2H) Il-a-20 Cl 6-Cl H c-hexyl- Me Et 1 H-NMR (400MHz, CDCIs, shift in ppm): CH 2 7.32 (dd, 2H); 7.14 (m, 1H); 4,32 (m, 4H); 3.40 and 3.21 (in each case s, together 3H); 2.58 and 2.42 (in each case d, together 2H); 1.90 - 1.60 (cluster of signals, 7H), 1.39 (m, 3H), 1.35 - 0.95 (cluster of signals, 4H) I1-a-21 Cl 6-Cl H Me 2-(4'-Cl- Me 'H-NMR (400MHz, CDC 3 , shift in ppm): phenyl)- 7.30 (m, 4H); 7.17 (m, 3H); 4,28 - 3.80 ethyl (cluster of signals 7H); 2.92 (m, 2H); 2.30 and 1.92 (in each case s, together 3H) I-a-22 Cl 4-Cl H Me 2-(4'-CI- Me 1 H-NMR (400MHz, CDC 3 , shift in ppm): phenyl)- 7.38 (d, 1H); 7.26 (d, 2H), 7.19 (dd, 1H), ethyl 7.13 (m, 3H); 4.05 (m, 2H), 3.93 and 3.62 (in each case s, together 2H), 3.88 (s, 3H), 2.85 (m, 2H); 2.30 and 1.92 (in each case s, together 3H) WO 2010/069525 PCT/EP2009/008908 81 No. X Y .. Z -A . BR Analytical data ll-a-23 Cl 4-Cl H Me 2-(2'-C- Me 1 H-NMR (400MHz, CDC3, shift in ppm): phenyl)- 7.42 - 7.11 (cluster of signals, 7H); 4.12 ethyl (m, 2H), 3.98 and 3.62 (in each case s, together 2H), 3.88 (s, 3H), 3.08 (in, 2H): 2.28 and 1.92 (in each case s, together 3H) 1l-a-24 Cl 6-CF 3 H Me 2-phenyl- Me 1 H-NMR (400MHz, CDClI, shift in ppm): ethyl 7.62 (m, 2H); 7.32 (m, 3H), 7.20 (m, 3H), 4.12 (m, 2H), 4.22 and 3.98 (in each case s, together 2H), 3.91 (s, 3H), 3.02 and 2.88 ( in each case t, together 2H); 2.33 and 1.85 (in each case s, together 3H) Il-a-25 I H H Me 2-(4'-C- Me 'H-NMR (400MHz, CDCla, shift in ppm): phenyl)- 7.82 (d, 1H); 7.30 (in, 3H), 7.15 (m, 3H), ethyl 6.96 (m, 1 H); 4.01 (m, 2H), 3.98 and 3.62 (in each case s, together 2H), 3.90 (s, 3H), 2.88 (m, 2H); 2.24 and 1.96 (in each case s, together 3H) Il-a-26 CI 4-Cl 6-Et c-pentyl- Me Et 'H-NMR (400MHz, CDC 3 , shift in ppm): CH 2 7.29 (d, IH); 7.12 (d, 1H), 4.32 (m, 2H), 4.12 (d, 2H), 3.38 and 3.22 (in each case s, together 3H), 2.58 (m, 4H), 1.90 - 1.60 (cluster of signals, 6H), 1.37 and 1.22 (in each case in, together 9H) 1l-a-27 Cl 6-Cl H c-pentyl- Me Et 'H-NMR (400MHz, CDCI 3 , shift in ppm): CH 2 7.33 (d, 2H); 7.15 (m, 1H), 4.32 (m, 4H), 3.40 and 3.22 (in each case s, together 3H), 2.80 and 2.55 (in each case d, together 2H), 1.90 - 1.60 (cluster of signals, 7H), 1.38 (in, 3H), and 1,20 (m, 2H) 1I-a-28 Cl 4-Cl H c-pentyl- Me Et 'H-NMR (400MHz, CDCl 3 , shift in ppm): CH 2 7.38 (s, 1H); 7.22 (m, 2H), 4.32 (q, 2H), 4.08 (s, 2H), 3.38 (s, 3H), 2.72 (d, 2H), 2.00 (m, 1H),1.68 8m, 4H), 1.53 (m, 2H), 1.38 (t, 3H), and 1.10 (m, 2H) II-a-29 CI 6-Cl H c-Pr Me Et 'H-NMR (400MHz, CDC13, shift in ppm): 7.31 (d, 2H); 7.12 (m, 1H), 4.31 (m, 2H), 4.22 (s, 2H), 3.48 (s, 3H), 1.90 (m, 1H), 1.36 (t, 3H), and 1.12 (m, 4H) Il-a-30 Cl Cl H CF 3 (CH 2 ) 2 Me Et 'H-NMR (400MHz, CDC13, shift in ppm): 7.33 (d, 2H); 7.15 (m, IH), 4.32 (m, 4H), 3.50 and 3.28 (in each case s, together 3H), 3.15 and 3.02 (in each case m, together 2H), 2.82 and 2.55 (in each case d, together 2H), 1.38 (m, 3H) WO 2010/069525 PCT/EP2009/008908 82 B. Formulation examples a) A dust is obtained by mixing 10 parts by weight of a compound of the formula (1) and/or a salt thereof and 90 parts by weight of talc as inert substance and 5 comminuting the mixture in a hammer mill. b) A wettable powder which is readily dispersible in water is obtained by mixing 25 parts by weight of a compound of the formula (1) and/or a salt thereof, 64 parts by weight of kaolin-containing quartz as inert substance, 10 parts by 0 weight of potassium lignosulfonate and 1 part by weight of sodium oleoylmethyltaurate as wetting agent and dispersant, and grinding the mixture in a pinned-disk mill. c) A readily water-dispersible dispersion concentrate is obtained by mixing 5 20 parts by weight of a compound of the formula (1) and/or a salt thereof with 6 parts by weight of alkylphenol polyglycol ether (@Triton X 207), 3 parts by weight of isotridecanol polyglycol ether (8 EO) and 71 parts by weight of paraffinic mineral oil (boiling range for example about 255 to above 277*C) and grinding the mixture in a ball mill to a fineness of below 5 microns. 0 d) An emulsifiable concentrate is obtained from 15 parts by weight of a compound of the formula (1) and/or a salt thereof, 75 parts by weight of cyclohexanone as solvent and 10 parts by weight of oxethylated nonylphenol as emulsifier. 5 e) Water-dispersible granules are obtained by mixing 75 parts by weight of a compound of the formula (1) and/or a salt thereof, 10 parts by weight of calcium lignosulfonate, 5 parts by weight of sodium lauryl sulfate, 3 3 parts by weight of polyvinyl alcohol and 7 parts by weight of kaolin, grinding the mixture in a pinned-disk mill, and granulating the powder in a WO 2010/069525 PCTIEP20091008908 83 fluidized bed by spraying on water as granulating liquid. f) Water-dispersible granules are also obtained by homogenizing and precomminuting 5 25 parts by weight of a compound of the formula (1), 5 parts by weight of sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, 2 parts by weight of sodium oleoylmethyltaurate, 1 parts by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate and 0 50 parts by weight of water in a colloid mill, then grinding the mixture in a bead mill, and atomizing and drying the resulting suspension in a spray tower, using a single-fluid nozzle. 5 C. Biological examples 1. Herbicidal pre-emergence effect against harmful plants Seeds of monocotyledonous or dicotyledonous weeds or crop plants are placed in sandy loam soil in wood-fiber pots and covered with soil. The compounds according to the invention, formulated in the form of wettable powders (WP) or emulsion 0 concentrates (EC), are then applied to the surface of the soil cover in the form of an aqueous suspension or emulsion at a water application rate of 600 to 800 I/ha (converted), with addition of 0.2% wetting agent. After the treatment, the pots are placed in the greenhouse and kept under good growth conditions for the test plants. The damage to the test plants is scored visually in comparison with untreated 5 controls after an experimental time of 3 weeks has elapsed (herbicidal activity in percent (%): 100% activity = plants have died, 0% activity = like control plants). Here, for example, the compounds Nos. 1-1-c-4 and I 1-1-c-7 show, at an application rate of 320 g/ha, each at least 90% activity against Echinochloa crus galli, Stellaria media and Veronica persica. 0 2. Herbicidal post-emergence activity against harmful plants Seeds of monocotyledonous or dicotyledonous weeds or crop plants are placed in WO 2010/069525 PCT/EP2009/008908 84 sandy loam soil in wood-fiber pots, covered with soil and grown in the greenhouse under good growth conditions. 2 to 3 weeks after sowing, the test plants are treated in the one-leaf stage. The compounds according to the invention, formulated in the form of wettable powders (WP) or emulsion concentrates (EC), are then sprayed 5 onto the green plant parts in the form of an aqueous suspension or emulsion at a water application rate of 600 to 800 I/ha (converted), with addition of 0.2% wetter. After the test plants have been left to stand under optimal growth conditions in the greenhouse for approximately 3 weeks, the activity of the preparations is scored visually in comparison with untreated controls (herbicidal activity in percent (%): 0 100% activity = plants have died, 0% activity = like control plants). Here, for example the compound No. I-1 -c-4 shows, at an application rate of 80 g/ha, at least 80% activity against Abutilon theophrasti, Alopecurus myosuroides, Avena fatua, Echinochloa crus galli, Lolium multiflorum, Setaria viridis and Veronica persica. 5 3. Insecticidal activity Example A Myzus test (MYZUPE spray treatment) Solvents: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide 0 Emulsifier: 0.5 part by weight of alkylaryl polyglycol ether To produce a suitable preparation of active compound, I part by weight of active compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with emulsifier-containing water to the desired concentration. Discs of Chinese cabbage (Brassica pekinensis) which are infested by all stages of 5 the green peach aphid (Myzus persicae) are sprayed with an active compound preparation of the desired concentration. After the desired period of time, the effect in % is determined. 100% means that all aphids have been killed; 0% means that none of the aphids have been killed. In this test, for example, the compound No. 1-1 a-4 shows, at an application rate of 500 g/ha, at least 80% activity. Example B Spodoptera frugiperda test (SPODFR spray treatment) WO 2010/069525 PCT/EP20091008908 85 Solvents: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: 0.5 part by weight of alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active 5 compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with emulsifier-containing water to the desired concentration. Discs of corn leaves (Zea mays) are sprayed with an active compound preparation of the desired concentration and, after drying, populated with caterpillars of the army worm (Spodoptera frugiperda). After the desired period of time, the effect in % is 0 determined. 100% means that all the caterpillars have been killed; 0% means that none of the caterpillars have been killed. In this test, for example, the compound No. l-1-a-9 shows, at an application rate of 500 g/ha, at least 80% activity. Example C 5 Meloidogyne incognita test (MELGIN) Solvents: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: 0.5 part by weight of alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active 0 compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with water to the desired concentration. Containers are filled with sand, solution of active compound, Meloidogyne incognita egg/larvae suspension and lettuce seeds. The lettuce seeds germinate and the plants develop. On the roots, galls are formed. After the desired period of time, the nematicidal 5 activity is determined in % by the formation of galls. 100% means that no galls are formed; 0% means that the number of galls on the treated plants corresponds to that of the untreated control. In this tett, for example, the compounds Nos. I-1-a-9 and 1-1-a-10 show, at an application rate of 20 ppm, an efficacy of at least 80%.
权利要求:
Claims (11) [1] 1. A 4-phenylpyridazinone of the formula (1) or salts thereof A OG N 5 B Xi) in which A is in each case independently of one another hydrogen, (C 3 -C 6 )-cycloalkyl or (C 0 C 6 )-alkyl substituted by n radicals from the group consisting of halogen, (C3-C6) cycloalkyl, phenyl and halophenyl, B is independently of one another (C3-Ce)-cycloalkyl or (C 1 -C 6 )-alkyl substituted by n radicals from the group consisting of halogen, (C3-C 6 )-cycloalkyl, phenyl and halophenyl; 5 m is 0,1, 2 or 3; n is 0, 1, 2 or 3, with the proviso that m and n are not both 0; ) G is hydrogen, C(=O)R 1 , C(=L)MR 2 , S0 2 R 3 , P(=L)RR 5 , C(=L)NRR 7 , E or R" E is a metal ion equivalent or an ammonium ion; L is oxygen or sulfur, M is oxygen or sulfur; R 1 is (C1-C 6 )-alkyl, (C 2 -Ce)-alkenyl, (C 1 -C4)-alkoxy-(C 1 -C 6 )-alkyl, di-(C 1 -C4)- WO 2010/069525 PCT/EP2009/008908 87 alkoxy-(C-C 8 )-alkyl or (C-C4)-aikylthio-(C-C 6 )-alkyl, each of which is substituted by n halogen atoms, a fully saturated 3- to 6-membered ring consisting of 3 to 5 carbon atoms and 1 to 3 heteroatoms from the group consiting of oxygen, sulfur and nitrogen which is 5 substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (C C4)-alkoxy, (C3-C 6 )-cycloalkyl, phenyl, phenyl-(C-C4)-alkyl, heteroaryl, phenoxy-(C-C 4 )-alkyl or heteroaryloxy-(C-C4)-alkyl substituted by n radicals from the group consisting of halogen, (Cr-C4)-alkyl and (C-C4)-alkoxy; 0 R 2 is (C-Ce)-alkyl, (C 2 -C 6 )-alkenyl, (C 1 -C 4 )-alkoxy-(C-C 6 )-alkyl or di-(C-C 4 ) alkoxy-(C-C 6 )-alkyl, each of which is substituted by n halogen atoms, or is (C3-C 6 )-cycloalkyl, phenyl or benzyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (C-C4)-alkoxy; 5 R 3 , R 4 and R' are each independently of one another (0 1 -Cr)-alkyl which is substituted by n halogen atoms, (C-C4)-alkoxy, N-(C-C 6 )-alkylamino, N,N-di-(Cr C 6 )-alkylamino, (C-C4)-alkylthio, (C 2 -C4)-alkenyl or (C 3 -C 6 )-cycloalkylthio, or phenyl, benzyl, phenoxy or phenylthio which is substituted by n radicals from the 0 group consisting of halogen, (C-C4)-alkyl and (C-C4)-alkoxy; R 6 and R 7 are each independently of one another hydrogen, (C-C 6 )-alkyl which is substituted by n halogen atoms, (C3-C 6 )-cycloalkyl, (C 2 -C 6 ) alkenyl, (CrCs)-alkoxy or (Ci-C 4 )-alkoxy-(C-C)-alkyl, 5 phenyl or benzyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C4)-alkyl and (C 1 -C 4 )-alkoxy; or R 6 and R 7 together with the nitrogen atom to which they are attached form a 3- to [2] 6-membered ring which contains 2 to 5 carbon atoms and 0 or 1 oxygen or sulfur atoms; D and WO 20101069525 PCT/EP2009/008908 88 a) X is hydrogen, (C-C 6 )-alkyl or (C 3 -C 6 )-cycloalkyl; Y is halogen, cyano, nitro, halo-(Cl-C 6 )-alkyl, halo-(C-C 6 )-alkoxy, (C 3 -Ce)-cycloalkyl, (C-Ce)-alkoxy or is phenyl which is substituted by n halogen atoms, 5 Z is hydrogen, halogen, cyano, nitro, (Oi-C 6 )-alkyl, halo-(C-C 6 )-alkyl, halo-(C 1 -C 6 )-alkoxy, (C3-C 6 )-cycloalkyl or is phenyl which is substituted by n halogen atoms; or 0 b) X is halogen, cyano, nitro or is (0 1 -Cr)-alkyl, (C 3 -C 6 )-cycloalkyl, (C-C 6 ) alkoxy or phenyl, each of which is substituted by n halogen atoms; Y and Z are each independently of one another hydrogen, halogen, cyano, nitro, (C 3 -C 6 )-cycloalkyl or are (0 1 -C 6 )-alkyl, (C-C6)-alkoxy or phenyl, each of 5 which is substituted by n halogen atoms. 2. The 4-phenylpyridazinone as claimed in claim 1 in which A is (C3-Cs)-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(Cr-C 6 )-alkyl, benzyl, halophenyl 0 (CrC 6 )-alkyl or is (C-C 6 )-alkyl which is substituted by n halogen atoms; B is (C3-C6)-cycloalkyl, (C3-C 6 )-cycloalkyl-(C-C 6 )-alkyl, benzyl, halophenyl (Cr-0)-alkyl or is (Ci-C 6 )-alkyl which is substituted by n halogen atoms; 5 m is 0, 1, 2 or 3; n is 0, 1, 2 or 3, with the proviso that m and n are not both 0; G is hydrogen, C(=O)R', C(=L)MR 2 , S0 2 R 3 , P(=L)R 4 R 5 , C(=L)NRR 7 , or E; E is Na*, K*, (Mg2+) 1 12 , (Ca2+)1/2 , R 13 R 14 R 15 RN 16 N or NH4*; WO 2010/069525 PCT/EP2009/008908 89 R 13 , R 14 , R 15 and R 16 are independently of one another (C-C)-alkyl or benzyl; L is oxygen; 5 M is oxygen; R 1 is (C-Cg)-alkyl which is substituted by n halogen atoms or is (C3-C6) cycloalkyl, phenyl or phenyl-(C-C4)-alkyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C 4 )-alkyl and (C-C4)-alkoxy; 0 R 2 is (C 1 -Ce)-alkyl which is substituted by n halogen atoms or is (C3-Cs) cycloalkyl, phenyl or benzyl, each of which is substituted by n radicals from the group consisting of halogen, (C-C 4 )-alkyl and (C-C4)-alkoxy; 5 R 3 , R 4 and R' are each independently of one another (C-C 6 )-alkyl which is substituted by n halogen atoms or are phenyl or benzyl which are substituted by n radicals from the group consisting of halogen, (C-C 4 )-alkyl and (Ci-C 4 )-alkoxy; R 6 and R 7 are each independently of one another hydrogen, (C-C6)-alkyl which is ) substituted by n halogen atoms or phenyl or benzyl which are substituted by n radicals from the group consisting of halogen, (C 1 -C4)-alkyl and (C -C4)-alkoxy; and 5 a) X is hydrogen, methyl, ethyl or cyclopropyl; Y is halogen, cyano, nitro, halo-(CrC 6 )-alkyl, halo-(C-C 6 )-alkoxy, (C3-C6)-cycloalkyl, (Ci-Ce)-alkoxy or phenyl which is substituted by n halogen atoms, Z is hydrogen, halogen, halo-(C-C 6 )-alkyl, halo-(0 1 -C 6 )-alkoxy, (C3-C6) cycloalkyl or phenyl which is substituted by n halogen atoms, or WO 2010/069525 PCT/EP2009/008908 90 b) X is halogen, cyano, nitro, halo-(CI-C 6 )-alkyl, halo-(C1-C 6 )-alkoxy, (C1-Ce)-alkoxy or (C3-C)-cycloalkyl; Y is hydrogen, halogen, cyano, nitro, (C3-C 6 )-cycloalkyl, is (C1-Cs)-alkyl, 5 (C1-C 6 )-alkoxy or phenyl, each of which is substituted by n halogen atoms; Z is hydrogen, halogen, cyano, nitro, (C 3 -C 6 )-cycloalkyl or is (C 1 -C 6 )-alkyl, (C1-C 6 )-alkoxy or phenyl, each of which is substituted by n halogen atoms. 0 3. The 4-phenylpyridazinone as claimed in claim 1 or 2 in which A is cyclopropyl, cyclopropylmethyl, benzyl, 2-chlorophenylmethyl, 3 chlorophenylmethyl or 4-chiorophenylmethyl; 5 B is hydrogen, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, cyclopropyl, cyclopropylmethyl, benzyl, 2-chlorophenylmethyl, 3-chlorophenylmethyl or 4-chloro phenylmethyl; ) G is hydrogen, C(=O)R, C(=L)MR 2 , S0 2 R 3 , P(=L)R 4 R 5 , C(=L)NR 6 R, E or R" E is Na*, K*, (Mg2+)1 2 , (Ca 2 +)1 2 , (CH 3 ) 4 N* or NH 4 *; L is oxygen; 5 M is oxygen; R 1 is (C 1 -C 6 )-alkyl or (C 3 -C 6 )-cycloalkyl; ) R 2 is (C1-Ce)-alkyl, (C 3 -C 6 )-cycloalkyl or benzyl; R 3 , R 4 and R 5 are each independently of one another (C 1 -C)-alkyl, phenyl or benzyl; WO 2010/069525 PCT/EP20091008908 91 R 6 and R 7 are each independently of one another hydrogen, (CI-C 6 )-alkyl, phenyl or benzyl; 5 and a) X is hydrogen, methyl or ethyl; Y is fluorine, bromine, chlorine, iodine, cyano, nitro, cyclopropyl, methoxy, ethoxy, trifluoromethyl or trifluoromethoxy, phenyl or 0 halophenyl; Z is hydrogen, fluorine, bromine, chlorine, iodine, methyl, ethyl, methoxy, ethoxy, trifluoromethyl or cyclopropyl; or 5 b) X is fluorine, bromine, chlorine, iodine, cyano, nitro, methoxy, ethoxy, trifluoromethyl, trifluoromethoxy or cyclopropyl; Y is hydrogen, fluorine, bromine, chlorine, iodine, methyl, ethyl, methoxy, ethoxy, trifluoromethyl, trifluoromethoxy or cyclopropyl; Z is hydrogen, fluorine, bromine, chlorine, iodine, methyl, ethyl, methoxy, 0 ethoxy, trifluoromethyl, trifluoromethoxy, cyclopropyl, chlorophenyl or fluorophenyl. 4. A herbicidal composition which comprises an effective amount of at least one 5 4-phenylpyridazinone of the formula (1) as claimed in any of claims 1 to 3. 5. The herbicidal composition as claimed in claim 4 as a mixture with formulation auxiliaries. 3 6. The herbicidal composition as claimed in claim 4 or 5 which comprises at least one further pesticidally active compound from the group consiting of insecticides, acaricides, herbicides, fungicides, safeners and growth regulators. WO 2010/069525 PCT/EP2009/008908 92 [3] 7. The herbicidal composition as claimed in claim 6 which comprises a safener. [4] 8. The herbicidal composition as claimed in claim 6 or 7 which comprises a 5 further herbicide. [5] 9. A method for controlling unwanted plants wherein an effective amount of at least one 4-phenylpyridazinone of the formula (1) as claimed in any of claims 1 to 3 or of a herbicidal composition as claimed in any of claims 4 to 8 is applied to the 0 plants or to the site where the unwanted plants are growing. [6] 10. The use of a 4-phenylpyridazinone of the formula (1) as claimed in any of claims 1 to 3 or of a herbicidal composition as claimed in any of claims 4 to 8 for controlling unwanted plants. 5 [7] 11. The use as claimed in claim 10 wherein the 4-phenylpyridazinone of the formula (1) is used for controlling unwanted plants in crops of useful plants. [8] 12. The use as claimed in claim 11 wherein the useful plants are transgenic D useful plants. [9] 13. A compounds of the formula (11), A C2 R z N y B 0 X in which the substituents A, B, X, Y and Z are as defined in any of claims 1 to 3 and R 9 is (CI-C6)-alkyl. WO 2010/069525 PCTIEP2009/008908 93 [10] 14. A compounds of the formula (Ila) H2N Z-q 2N y (Ila) in which the substituents B, X, Y and Z are as defined in any of claims 1 to 3. 5 [11] 15. The use of a 4-phenylpyridazinone of the formula (1) as claimed in any of claims 1 to 3 as insecticides.
类似技术:
公开号 | 公开日 | 专利标题 US8188008B2|2012-05-29|Herbicidally and insecticidally active 4-phenyl-substituted pyridazinones AU2017204231C9|2021-05-13|Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators DK2691379T3|2017-02-13|HERBICID AND FUNGICID ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES AND 3-PHENYLISOXAZOLIN-5-THIOAMIDES AU2012350749A1|2014-07-10|N-|, N-|, N-|, and N-| aryl carboxylic acid amides and use thereof as herbicides AU2012228355A1|2013-10-03|N-|-, N-|- and N-|bicycloarylcarboxamides and their use as herbicides US20110053778A1|2011-03-03|2-|-3-cyclopropyl-3-oxopropanenitriles and their use as herbicides US8188009B2|2012-05-29|4-|-5-cyclopropylisoxazoles effective as herbicides US20110118118A1|2011-05-19|Herbicidally active phenyl-substituted pyridazinones CN103189376B|2016-02-24|There is ketone group sultam and the diketo pyridine of weeding activity US20120065065A1|2012-03-15|Herbicidally active pyridylketosultams
同族专利:
公开号 | 公开日 JP5651601B2|2015-01-14| AR074774A1|2011-02-09| WO2010078912A1|2010-07-15| CN102325756A|2012-01-18| US20100184602A1|2010-07-22| US20110003692A1|2011-01-06| JP2012512211A|2012-05-31| AR074773A1|2011-02-09| WO2010078912A8|2011-07-14| WO2010069526A1|2010-06-24| AR075673A1|2011-04-20| JP2012512209A|2012-05-31| JP5651602B2|2015-01-14| EP2204366A1|2010-07-07| EP2379509B1|2016-02-17| CA2747638A1|2010-07-15| BRPI0922428A2|2015-08-11| US8242055B2|2012-08-14| AU2009336854A8|2011-12-01| WO2010069525A1|2010-06-24| CN106928148A|2017-07-07| BRPI0922428B1|2018-07-10| US20100173775A1|2010-07-08| CN105732513A|2016-07-06| BRPI0923035A2|2018-10-16| EP2379508B1|2014-06-04| EP2379509A1|2011-10-26| AU2009336854A1|2011-07-21| CA2747639A1|2010-06-24| EP2379508A1|2011-10-26| CN102325757A|2012-01-18| US8188008B2|2012-05-29|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 CA92064A|1905-02-23|1905-03-14|James E. Toscan|Detachable ice creeper| WO1984002919A1|1983-01-17|1984-08-02|Monsanto Co|Plasmids for transforming plant cells| BR8404834A|1983-09-26|1985-08-13|Agrigenetics Res Ass|METHOD TO GENETICALLY MODIFY A PLANT CELL| BR8600161A|1985-01-18|1986-09-23|Plant Genetic Systems Nv|CHEMICAL GENE, HYBRID, INTERMEDIATE PLASMIDIO VECTORS, PROCESS TO CONTROL INSECTS IN AGRICULTURE OR HORTICULTURE, INSECTICIDE COMPOSITION, PROCESS TO TRANSFORM PLANT CELLS TO EXPRESS A PLANTINIDE TOXIN, PRODUCED BY CULTURES, UNITED BY BACILLA| AT80182T|1985-10-25|1992-09-15|Monsanto Co|PLANT VECTORS.| ES2018274T5|1986-03-11|1996-12-16|Plant Genetic Systems Nv|VEGETABLE CELLS RESISTANT TO GLUTAMINE SYNTHETASE INHIBITORS, PREPARED BY GENETIC ENGINEERING.| IL83348A|1986-08-26|1995-12-08|Du Pont|Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase| US5013659A|1987-07-27|1991-05-07|E. I. Du Pont De Nemours And Company|Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase| AT241007T|1990-03-16|2003-06-15|Calgene Llc|DNAS CODING FOR VEGETABLE DESATURASES AND THEIR APPLICATIONS| JP3325022B2|1990-06-18|2002-09-17|モンサントカンパニー|Increased starch content in plants| CA2083948C|1990-06-25|2001-05-15|Ganesh M. Kishore|Glyphosate tolerant plants| SE467358B|1990-12-21|1992-07-06|Amylogene Hb|GENETIC CHANGE OF POTATISE BEFORE EDUCATION OF AMYLOPECT TYPE STARCH| DE4104782B4|1991-02-13|2006-05-11|Bayer Cropscience Gmbh|Novel plasmids containing DNA sequences that cause changes in carbohydrate concentration and carbohydrate composition in plants, as well as plants and plant cells containing these plasmids| GB9418545D0|1994-09-15|1994-11-02|Merck Sharp & Dohme|Therapeutic agents| HU9800031A3|1995-02-13|1998-06-29|Bayer Ag|2-phenyl-substituted heterocyclic ketoenols, intermediates, preparation and use thereof, pesticide and herbicide compositions containing these compounds as active ingredients| CN1221514C|1995-05-09|2005-10-05|拜尔公司|Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol| JPH11140055A|1997-09-01|1999-05-25|Nissan Chem Ind Ltd|6-haloalkyl-3-substituted phenyl-2-pyridinone derivative and herbicide| JPH11152273A|1997-11-19|1999-06-08|Otsuka Chem Co Ltd|Six-membered cyclic dione derivative containing nitrogen| DE10029413A1|2000-06-15|2001-12-20|Bayer Ag|Production of 2,3,4,6-tetramethylmandelic acid or derivatives, some of which are new compounds, comprises reacting a technical durene/isodurene mixture with glyoxylic acid| DE10325133A1|2003-06-04|2004-12-23|Bayer Cropscience Ag|triazolopyrimidines| DE10354628A1|2003-11-22|2005-06-16|Bayer Cropscience Ag|2-ethyl-4,6-dimethylphenyl-substituted tetramic acid derivatives| DE102004005318A1|2004-02-04|2005-08-25|Bayer Cropscience Ag|Process for the preparation of 2,5-dimethylphenylacetic acid| WO2007014054A2|2005-07-22|2007-02-01|Glaxo Group Limted|Benzenesulfonamide inhibitor of ccr2 chemokine receptor| TWI375669B|2006-03-17|2012-11-01|Sumitomo Chemical Co|Pyridazinone compound and use thereof| JP5040383B2|2006-03-17|2012-10-03|住友化学株式会社|Pyridazinone compound and herbicide containing the same| FR2903325B1|2006-07-06|2009-02-06|Air Liquide|METHOD AND APPARATUS FOR INJECTING DIRECTION FLUID JET AND / OR VARIABLE OPENING| JP2009067740A|2007-09-14|2009-04-02|Sumitomo Chemical Co Ltd|Herbicidal composition| CL2008002703A1|2007-09-14|2009-11-20|Sumitomo Chemical Co|Compounds derived from 1,4-dihydro-2h-pyridazin-3-one; herbicidal composition comprising said compounds; weed control method; use of said compounds for weed control; and intermediate compounds.| CL2008003785A1|2007-12-21|2009-10-09|Du Pont|Pyridazine derived compounds; herbicidal compositions comprising said compounds; and method of controlling the growth of unwanted vegetation.|US20080255134A1|2004-11-30|2008-10-16|Artesian Therapeutics, Inc.|Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase| TWI375669B|2006-03-17|2012-11-01|Sumitomo Chemical Co|Pyridazinone compound and use thereof| US8097712B2|2007-11-07|2012-01-17|Beelogics Inc.|Compositions for conferring tolerance to viral disease in social insects, and the use thereof| US8962584B2|2009-10-14|2015-02-24|Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd.|Compositions for controlling Varroa mites in bees| WO2011045271A1|2009-10-15|2011-04-21|Bayer Cropscience Ag|Herbicidally active, heterocyclyl-substituted pyridazinones| US9121022B2|2010-03-08|2015-09-01|Monsanto Technology Llc|Method for controlling herbicide-resistant plants| JP5842594B2|2010-12-27|2016-01-13|住友化学株式会社|Pyridazinone compounds, herbicides containing them, and harmful arthropod control agents| MX350774B|2011-09-13|2017-09-15|Monsanto Technology Llc|Methods and compositions for weed control.| UA115534C2|2011-09-13|2017-11-27|Монсанто Текнолоджи Ллс|Methods and compositions for weed control| EP3296402B1|2011-09-13|2020-04-15|Monsanto Technology LLC|Methods and compositions for weed control| US10760086B2|2011-09-13|2020-09-01|Monsanto Technology Llc|Methods and compositions for weed control| WO2013040057A1|2011-09-13|2013-03-21|Monsanto Technology Llc|Methods and compositions for weed control| US10806146B2|2011-09-13|2020-10-20|Monsanto Technology Llc|Methods and compositions for weed control| EP3382027A3|2011-09-13|2018-10-31|Monsanto Technology LLC|Methods and compositions for weed control| US9840715B1|2011-09-13|2017-12-12|Monsanto Technology Llc|Methods and compositions for delaying senescence and improving disease tolerance and yield in plants| MX350773B|2011-09-13|2017-09-15|Monsanto Technology Llc|Methods and compositions for weed control.| EP2755987B1|2011-09-13|2018-06-06|Monsanto Technology LLC|Methods and compositions for weed control| US10829828B2|2011-09-13|2020-11-10|Monsanto Technology Llc|Methods and compositions for weed control| BR112014005979A2|2011-09-13|2017-06-13|Monsanto Technology Llc|Weed control methods and compositions| US9920326B1|2011-09-14|2018-03-20|Monsanto Technology Llc|Methods and compositions for increasing invertase activity in plants| GB201117019D0|2011-10-04|2011-11-16|Syngenta Ltd|Herbicidal compounds| US10240162B2|2012-05-24|2019-03-26|A.B. Seeds Ltd.|Compositions and methods for silencing gene expression| WO2014062989A2|2012-10-18|2014-04-24|Monsanto Technology Llc|Methods and compositions for plant pest control| WO2014106837A2|2013-01-01|2014-07-10|A. B. Seeds Ltd.|ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST| US10683505B2|2013-01-01|2020-06-16|Monsanto Technology Llc|Methods of introducing dsRNA to plant seeds for modulating gene expression| US10000767B2|2013-01-28|2018-06-19|Monsanto Technology Llc|Methods and compositions for plant pest control| WO2014119770A1|2013-01-30|2014-08-07|住友化学株式会社|Pyridazinone compound and herbicide comprising same| WO2014164797A2|2013-03-13|2014-10-09|Monsanto Technology Llc|Methods and compositions for weed control| UA123082C2|2013-03-13|2021-02-17|Монсанто Текнолоджи Ллс|Methods and compositions for weed control| US20140283211A1|2013-03-14|2014-09-18|Monsanto Technology Llc|Methods and Compositions for Plant Pest Control| US10568328B2|2013-03-15|2020-02-25|Monsanto Technology Llc|Methods and compositions for weed control| US9850496B2|2013-07-19|2017-12-26|Monsanto Technology Llc|Compositions and methods for controlling Leptinotarsa| PL3030663T3|2013-07-19|2020-04-30|Monsanto Technology Llc|Compositions and methods for controlling leptinotarsa| CN105849266A|2013-11-04|2016-08-10|孟山都技术公司|Compositions and methods for controlling arthropod parasite and pest infestations| EP3080147B1|2013-12-10|2019-03-13|Beeologics, Inc.|Compositions and methods for virus control in varroa mite and bees| AU2015206585A1|2014-01-15|2016-07-21|Monsanto Technology Llc|Methods and compositions for weed control using EPSPS polynucleotides| BR112016022711A2|2014-04-01|2017-10-31|Monsanto Technology Llc|compositions and methods for insect pest control| MY176467A|2014-04-29|2020-08-11|Fmc Corp|Pyridazinone herbicides| CN106795515B|2014-06-23|2021-06-08|孟山都技术公司|Compositions and methods for modulating gene expression via RNA interference| GB201412735D0|2014-07-17|2014-09-03|Syngenta Participations Ag|Herbicidal compounds| RU2021123470A|2014-07-29|2021-09-06|Монсанто Текнолоджи Ллс|COMPOSITIONS AND METHODS FOR COMBATING PESTS| CA2974101A1|2015-01-22|2016-07-28|Monsanto Technology Llc|Compositions and methods for controlling leptinotarsa| GB201507464D0|2015-04-30|2015-06-17|Syngenta Participations Ag|Herbicidal compounds| AU2016270870A1|2015-06-02|2018-01-04|Monsanto Technology Llc|Compositions and methods for delivery of a polynucleotide into a plant| WO2016196782A1|2015-06-03|2016-12-08|Monsanto Technology Llc|Methods and compositions for introducing nucleic acids into plants| GB2546336A|2016-01-18|2017-07-19|Syngenta Participations Ag|Intermediate compounds| JP2021008405A|2017-09-27|2021-01-28|石原産業株式会社|Pyridazinone-based compound or salt thereof, and herbicide containing the same|
法律状态:
2014-07-10| MK4| Application lapsed section 142(2)(d) - no continuation fee paid for the application|
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 EP08022104A|EP2204366A1|2008-12-19|2008-12-19|Herbicidal and insecticidal phenyl-substituted pyridazinones| EP08022104.7||2008-12-19|| PCT/EP2009/008908|WO2010069525A1|2008-12-19|2009-12-12|Herbicidally and insecticidally effective 4-phenyl-substitued pyridazinones| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|